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A B S T R A C T   
Oxidative stress resulting from the accumulation of high levels of reactive oxygen species is a salient feature of, 
and a well-recognised pathological factor for, diverse pathologies. One common mechanism for oxidative stress 
damage is via the disruption of intracellular ion homeostasis to induce cell death. TRPM2 is a non-selective Ca2+- 
permeable cation channel with a wide distribution throughout the body and is highly sensitive to activation by 
oxidative stress. Recent studies have collected abundant evidence to show its important role in mediating cell 
death induced by miscellaneous oxidative stress-inducing pathological factors, both endogenous and exogenous, 
including ischemia/reperfusion and the neurotoxicants amyloid-β peptides and MPTP/MPP+ that cause neuronal 
demise in the brain, myocardial ischemia/reperfusion, proinflammatory mediators that disrupt endothelial 
function, diabetogenic agent streptozotocin and diabetes risk factor free fatty acids that induce loss of pancreatic 
β-cells, bile acids that damage pancreatic acinar cells, renal ischemia/reperfusion and albuminuria that are 
detrimental to kidney cells, acetaminophen that triggers hepatocyte death, and nanoparticles that injure peri-
cytes. Studies have also shed light on the signalling mechanisms by which these pathological factors activate the 
TRPM2 channel to alter intracellular ion homeostasis leading to aberrant initiation of various cell death path-
ways. TRPM2-mediated cell death thus emerges as an important mechanism in the pathogenesis of conditions 
including ischemic stroke, neurodegenerative diseases, cardiovascular diseases, diabetes, pancreatitis, chronic 
kidney disease, liver damage and neurovascular injury. These findings raise the exciting perspective of targeting 
the TRPM2 channel as a novel therapeutic strategy to treat such oxidative stress-associated diseases.   
1. Introduction 
Mammalian cells under physiological conditions generate a small 
quantity of reactive oxygen species (ROS) during normal cellular 
metabolism [1]. It is recognised that ROS at low to moderate concen-
trations serve to modulate various cellular signalling pathways and 
regulate cell fate and proliferation, thereby playing an important part in 
maintaining cellular and tissue homeostasis [1]. ROS are chemically 
reactive and can potently modify many biological macromolecules such 
as nucleic acids, proteins and lipids. Phagocytes thus produce a large 
amount of ROS via membrane-bound nicotinamide adenine dinucleo-
tide phosphate (NADPH) oxidases (NOX) as weaponry to destroy 
invading pathogens during immune responses [2,3]. Conceivably, 
exposure to high levels of ROS is also harmful to healthy cells and tis-
sues, significantly disrupting their physiological functions and even 
causing them to die. Mammalian cells express multiple ROS-scavenging 
mechanisms that equip them with an antioxidant capacity [4]. However, 
a variety of pathological factors, both endogenous and exogenous, for 
example, reperfusion following transient ischemia, accumulation and 
aggregation of amyloid-β (Aβ) peptides, misfolded α-synuclein proteins, 
mitochondrial dysfunction, metabolism, infection, drug overdose, 
nanoparticles (NPs) and particulate matters (PMs) in polluted ambient 
air, are known to stimulate excessive generation of ROS, impair the 
antioxidant capacity of cells, or both [5–14]. Such an imbalance can lead 
to the accumulation of ROS at high levels that induces a noxious con-
dition termed oxidative stress (OS) [4]. A wealth of evidence exists to 
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indicate that OS is an important pathological factor for, as well as a 
salient feature of, various diseases and conditions, including ische-
mia/reperfusion (I/R) damage, Alzheimer’s disease (AD), Parkinson’s 
disease (PD), amyotrophic lateral sclerosis, neurovascular dysfunction, 
cardiovascular disorders, diabetes, pancreatitis, chronic kidney disease, 
liver injury, hearing loss, inflammatory diseases, and cancers [3,6,7,10, 
15–28]. 
A salient and recurring feature in many, if not all, of these patho-
logical processes is the dysregulation of ionic mechanisms, with a sub-
stantial impact on intracellular ion homeostasis, particularly Ca2+, 
which is well known for its ubiquitous role in determining the patho-
logical processes as well as the physiological functions of cells, and also 
Zn2+, which is notorious for its ability to induce neurotoxicity. 
Mammalian cells express a repertoire of ion-transporting mechanisms, 
including numerous ion channels that are important to maintain and 
regulate intracellular ionic homeostasis. Transient receptor potential 
melastatin 2 (TRPM2) belongs to the transient receptor potential (TRP) 
channel superfamily and forms a non-selective Ca2+-permeable cation 
channel gated by intracellular ADP-ribose (ADPR) [29,30]. The TRPM2 
channel is widely distributed throughout the body and is highly sensitive 
Table 1 
Summary of TRPM2-mediated cell death linking oxidative stress-inducing pathological factors to associated pathologies.  





Neurons I/R Unclear Ischemic stroke  • OGD/R-induced delayed neuronal death in mouse cortical, hippocampal and striatal 
neurons was attenuated by 2-APB, ACA, FFA, CTZ, or TRPM2-shRNA introduced before 
OGD, and CTZ after reoxygenation [35,135]  
• OGD/R-induced delayed neuronal death in mouse cortical and pyramidal neurons was 
reduced by TRPM2-KO [40,136]  
• MCAO/R-induced neuronal death and infarction in the striatum of mice was attenuated by 
CTZ or TRPM2-shRNA [35]  
• MCAO/R-induced brain damage in mice was attenuated by CTZ after MCAO [136], 
tat-M2NX prior to MCAO [120], or reduced by TRPM2-KO [37,136,137]  
• BCCAO/R-induced neuronal death in the hippocampus and cognitive dysfunction in mice 
was rescued by TRPM2-KO [40]  
• CA/R-induced neuronal death in the hippocampus in mice was mitigated by TRPM2-KO 
[138] 
Aβ42 Unclear Alzheimer’s disease  • Aβ42-induced neuronal death in rat striatal neurons was reduced by TRPM2-siRNA or 
overexpression of TRPM2-S [75]  
• Aβ42-induced neuronal death in mouse hippocampal neurons was reduced by 2-APB or 
ACA, and abolished by TRPM2-KO [82]  
• Synapse loss in the hippocampus and age-related memory impairment in APP/PS1 mice 
were salvaged by TRPM2-KO [42] 
MPTP/ 
MPP+
Apoptosis Parkinson’s disease  • Increased TRPM2 expression in the SNpc of human PD brains and MPTP-induced mouse 
brains [44]  
• MPP+-induced cell death in SH-SY5Y cells was attenuated by FFA or TRPM2-siRNA [44] 




• ZnO-NPs-induced autophagy and apoptosis in human brain pericytes was reduced by 
TRPM2-siRNA [161]  
• ZnO-NPs-induced autophagy and loss of brain pericytes in mice were attenuated by 
TRPM2-KO [161] 
Cardiomyocytes TNF-α, I/R Apoptosis Cardiovascular 
diseases  
• TNF-α-induced cell death in neonatal rat cardiomyocytes was prevented by CTZ or an anti- 
TRPM2 blocking antibody [165]  
• I/R-induced infarcts in the myocardium and increase in left ventricular pressure in mice 
were reduced by TRPM2-KO [166] 
Endothelial cells TNF-α, GO Apoptosis Vascular diseases  • TNF-α-induced reduction in HS5 cell viability was attenuated by TRPM2-shRNA or an anti- 
TRPM2 blocking antibody [181]  
• GO-induced apoptotic cell death in human pulmonary artery endothelial cells was 
attenuated by TRPM2-siRNA or an anti-TRPM2 blocking antibody [77]  
• Endothelial cell apoptosis in the lung vessels of mice induced by perfusion with GO was 
attenuated by TRPM2-KO [77] 
Pancreatic β-cells STZ Apoptosis Type 1 diabetes  • STZ-induced loss of pancreatic β-cells and hyperglycaemia in mice was prevented by 
TRPM2-KO [36] 
Palmitate Apoptosis Type 2 diabetes  • Palmitate-induced apoptosis in INS-1832/12 cells was inhibited by TRPM2-siRNA [121]  
• Palmitate-induced cell death in pancreatic islets from mice was reduced by TRPM2-KO 
[121]  
• Cell death in human pancreatic islets induced by palmitate, IL-1β and IFN-γ in combination 
was attenuated by ACA or TRPM2-siRNA [121] 
Pancreatic acinar cells Bile acids Necrosis Acute biliary 
pancreatitis  
• CDC-induced cell death in mouse pancreatic acinar cells was attenuated by TRPM2-KO [46] 
Kidney tubular epithelial 
cells 
I/R Apoptosis Acute kidney injury  • I/R-induced kidney injury and dysfunction in mice was reduced by 2-APB or TRPM2-KO 
[38]  
• I/R-induced kidney injury was prevented by 8-Br-cADPR [112]  
• I/R-induced tubular epithelial cell apoptosis in kidneys from mice was reduced by TRPM2- 
KO [38] 
Kidney cortical 
collecting duct cells 
Albumin Apoptosis Chronic kidney 
disease  
• BSA-induced apoptosis in mpkCCDc14 cells was reduced by ACA [203] 
Hepatocytes APAP Apoptosis Liver damage  • APAP-induced cell death in rat hepatocytes was inhibited by ACA [41]  
• APAP-induced reduction in the viability of mouse hepatocytes was suppressed by CTZ 
[206]  
• APAP-induced hepatic necrosis and liver damage in mice was reduced by TRPM2-KO [41] 
Abbreviations: Aβ, amyloid-β; APAP N-acetyl-para-aminophenol; APP/PS1, amyloid precursor protein/presenilin 1; BCCAO/R, bilateral common carotid artery oc-
clusion/reperfusion; BSA, bovine serum albumin; CDC, chenodeoxycholate; GO, glucose oxidase; IFN, interferon; IL, interleukin; I/R, ischemia/reperfusion; MCAO/R, 
middle cerebral artery occlusion/reperfusion; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NPs, nanoparticles; OGD/ 
R, oxygen-glucose deprivation/reoxygenation; SNpc, substantia nigra pars compacta; STZ, streptozotocin; TNF-α, tumour necrosis factor-α. 
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to activation by OS-inducing stimuli [31–33]. A large number of studies 
have been carried out over the past decades that provide compelling 
evidence to show that the TRPM2 channel is a key mechanism mediating 
OS-induced alteration in intracellular Ca2+ and Zn2+ homeostasis to 
disrupt various cellular functions and further support a significant role 
for aberrant TRPM2 channel activity in diverse OS-associated pathol-
ogies [34–48]. A well-established mechanism, among others, by which 
the TRPM2 channel contributes to these pathological processes, is to 
mediate OS-induced cell death. Considering such a prominent role for 
the TRPM2 channel, increasing research efforts are being devoted to 
understanding the mechanisms of TRPM2 channel activation and the 
consequences on intracellular ion homeostasis and downstream signal-
ling pathways leading to cell death. In this review, we will give a brief 
introduction of the TRPM2 channel, and provide an overview of the 
current understanding of TRPM2-mediated cell death as a cellular 
mechanism that links miscellaneous OS-inducing pathological factors to 
associated pathological or diseased conditions (Table 1). 
2. TRPM2 channel properties, activation mechanisms, and 
pharmacological inhibitors 
2.1. Molecular, structural and functional properties 
TRP channels were originally discovered in the genetic study of the 
visual signal transduction pathway in Drosophila melanogaster [49]. The 
subsequent search for the mammalian counterparts led to identification 
of a large superfamily, consisting of 28 members that are often grouped 
into TRPA (ankyrin), TRPC (canonical), TRPM (melastatin), TRPML 
(mucolipin), TRPP (polycystin) and TRPV (vanilloid) subfamilies, ac-
cording to amino acid sequence relatedness [50–52]. All TRP proteins 
can form non-selective cation channels, mainly as homo-tetramers and 
also as hetero-tetramers, with most of them being Ca2+-permeable. 
Despite sharing similar structural arrangements, these channels exhibit 
distinct and frequently multi-modal activation mechanisms in response 
to a wide array of chemical, physical and biological stimuli, and serve an 
important role in a variety of physiological and pathophysiological 
processes [50,51]. 
The gene encoding the TRPM2 protein has been isolated from several 
mammalian species including humans. The human TRPM2 gene, located 
on chromosome 21q22.3, is around 90 kb in length and contains 32 
exons [53]. Mammalian TRPM2 proteins are approximately 170 kDa in 
size and have a membrane-spanning domain comprising of six trans-
membrane segments (S1–S6) and exceptionally large N- and C-termini 
residing intracellularly [30,53] (Fig. 1A). Cryo-electron microscopy 
(cryo-EM) structures of the tetrameric human TRPM2 channel confirm 
that S5 and S6, together with the re-entrant loop between them, from all 
four subunits, form an aqueous pore through the centre of the protein 
complex that is permeable to Ca2+, Na+ and K+, while S1–S4 constitute a 
distinct structural module that is positioned peripherally to the 
pore-forming module [54,55]. The N-terminus of each subunit contains 
four TRPM homology regions (MHR1-4) [56] and the C-terminus has a 
conserved coiled-coil tetramerization domain [57,58] and a NUDT9-H 
domain that exhibits noticeable homology to the ADPR-metabolising 
enzyme NUDT9 (Fig. 1A). In mammalian TRPM2 channels, this 
NUDT9-H domain has little ADPR-degrading ability [59] but provides a 
critical ADPR-binding site and confers TRPM2 channel activation by 
intracellular ADPR [30,60,61]. 
In addition to ADPR, several ADPR analogues have been reported to 
activate the TRPM2 channel, including ADPR-2′-phosphate, 2′-O-acetyl- 
ADPR, 2′-deoxy-ADPR and cyclic ADPR (cADPR) [62–67] (Fig. 1B). 
Whether cADPR is capable of activating the TRPM2 channel has been a 
matter of debate, mainly due to the fact that commercially available 
cADPR may be significantly contaminated with ADPR. In a recent study 
examining the effects of introducing point mutations in the NUDT9-H 
domain on the binding and activation of the human TRPM2 channel 
by purified cADPR, we provide strong evidence to favour cADPR as a 
TRPM2 channel activator [68]. Intracellular Ca2+ is critical for TRPM2 
channel activation by ADPR [30,69,70]. The complex gating mechanism 
Fig. 1. The molecular and activation properties of 
the TRPM2 channel. 
(A) A cartoon representation of the tetrameric TRPM2 
channel and its subunit, which is comprised of 6 
transmembrane domains (S1–S6) with a re-entrant 
loop between S5 and S6 that forms a pore perme-
able to Ca2+, K+ and Na+. The intracellular N-termi-
nus contains four MHR (1–4), and the intracellular C- 
terminus contains aCC tetramerization domain and a 
NUDT9-H domain. The TRPM2 channel is activated 
by binding of intracellular ADPR at two sites, the 
MHR1/2 and NUDT9-H domain, and Ca2+ binding to 
the intracellular face of the transmembrane domain 
(not depicted). (B) ADPR and structurally related 
compounds that activate the TRPM2 channel, with 
the reported EC50 value shown in brackets where 
available. (C) Activation of the TRPM2 channel by 
ROS. Accumulation of intracellular ROS, resulting 
from exposure to extracellular ROS, increased intra-
cellular ROS generation or decreased antioxidant ca-
pacity, induces activation of PARP and PARG 
enzymes in the nucleus that convert NAD+ to ADPR. 
ADPR diffuses into the cytosol and opens the TRPM2 
channel, permitting Ca2+ influx to increase intracel-
lular Ca2+ concentration, or activates the TRPM2 
channel in intracellular organelles (not depicted). 
Abbreviations: ADPR, ADP-ribose; CC, coiled-coil; 
EC50, the concentration evoking 50% of the 
maximal response; MHR: TRPM homology regions; 
NAD+, nicotinamide adenine dinucleotide; NUDT9-H: 
NUDT9 homology; PARG, poly(ADPR) glycohy-
drolase; PARP, poly(ADPR) polymerase; ROS, reac-
tive oxygen species.   
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for the mammalian TRPM2 channel by ADPR and Ca2+ is still not fully 
delineated and nonetheless cryo-EM structures of the human TRPM2 
channel in the absence or presence of ADPR, Ca2+ or both ligands have 
shed light on how the binding of ADPR and Ca2+ induces channel 
opening [54,55]. In the closed state, the NUDT9-H domain interacts 
with the MHR1/2 of the same subunit as well as with the MHR1/2 from 
a neighbouring subunit. ADPR binding primes the channel for opening 
by eliciting conformational changes that rotate the MHR1/2 and thereby 
disengage the inter-subunit interaction, and binding of Ca2+ to a site in 
the intracellular S2–S3 loop [54] or within the intracellular side of the 
TRPM2 channel [55] induces additional conformational changes that 
open the ion-conducting channel. Surprising, but important to mecha-
nistic understanding of TRPM2 channel activation, is that a recent 
cryo-EM structural study has unambiguously revealed two 
ADPR-binding sites, the MHR1/2 as well as the NUDT9-H domain, and 
suggests that the MHR1/2 site is the orthostatic site while ADPR binding 
to the NUDT9-H domain elicits additional conformational changes for 
channel activation [55]. 
In addition to the full-length protein, several alternative splice 
variant isoforms of TRPM2 have been identified, including TRPM2-S 
made of only the N-terminus and the first two transmembrane seg-
ments, TRPM2-ΔN containing a deletion of 538–557 amino acid resi-
dues in the N-terminus, TRPM2-ΔC with a deletion of 1292–1325 
residues in the C-terminus, TRPM2-SSF (striatal short form) lacking 
residues 1–214 in the N-terminus, and TRPM2-TE (tumour-enriched) 
comprised of a large part of the NUDT9-H domain [32,33,71–73]. The 
TRPM2-S protein is of particular interest in that while short of 
channel-forming ability, it is capable of co-assembling with the 
full-length TRPM2 protein or channel and imposing dominant negative 
inhibition of the TRPM2 channel. Due to limited pharmacological tools 
for investigating the TRPM2 channel as discussed below, this dominant 
negative attribute of TRPM2-S has been employed in in vitro studies to 
interrogate the role of the TRPM2 channel in mediating ROS-induced 
Ca2+ signalling and regulation of cellular functions by overexpression 
of TRPM2-S to suppress the formation or activity of functional channels 
by the endogenous full-length TRPM2 protein [33,74–77]. 
Mammalian TRPM2 channels exhibit a widespread distribution, as 
has been documented in a number of tissues and cells including the 
brain, heart, blood vessels, kidney, liver, lung, pancreas and various 
immune cells [78]. The TRPM2 channel functions as a Ca2+-permeable 
channel in the plasma membrane of all cell types examined so far, with 
only the exception of dendritic cells where it is exclusively localised to 
the lysosomes and serves as a lysosomal Ca2+ release channel [79]. The 
TRPM2 channel is also present in the lysosomes of pancreatic β-cells and 
possibly endothelial cells [36,80,81] and in the mitochondria of hip-
pocampal neurons [82]. There is increasing evidence to support an 
important role for the TRPM2 channel in mediating or regulating many 
physiological processes, such as insulin secretion, inflammatory cyto-
kine production, phagosome maturation and temperature sensing, and 
interested readers can consult reviews on these topics [13,83–88]. 
2.2. ROS-induced activation mechanisms 
ROS are mostly short-lived, such as hydroxyl radicals (•OH), super-
oxide anions (O2•− ) and peroxynitrite (OONO− ). Hydrogen peroxide 
(H2O2) is relatively stable and thus widely used as an experimental 
paradigm in the study of OS signalling. While an early study suggested 
that H2O2 directly activated the TRPM2 channel, it is now generally 
accepted that H2O2-induced TRPM2 channel activation is indirect via 
mechanisms that generate ADPR from nicotinamide adenine dinucleo-
tide (NAD+). One such widely-documented mechanism is activation of 
poly(ADPR)-polymerase (PARP), particularly PARP-1, and poly(ADPR)- 
glycohydrolase (PARG) enzymes in the nucleus (Fig. 1C), a common 
DNA damage repairing mechanism [73,74,89–91]. Some evidence also 
suggests that activation of mitochondrial NADase is another mechanism 
for H2O2-induced ADPR generation and TRPM2 channel activation [92]. 
Since early in vitro studies that established a role for the TRPM2 channel 
in conferring susceptibility to H2O2-induced cell death in human em-
bryonic kidney (HEK) 293 cells expressing recombinant mammalian 
TRPM2 channels [31,33,89], extensive efforts have been directed to-
wards examining the importance of endogenous TRPM2 channels in 
mammalian cells in coupling a wide spectrum of OS-inducing patho-
logical factors, as discussed below, to their profound impacts on cellular 
functions and, furthermore, the pathogenesis and progression of asso-
ciated pathological conditions [73,78,83–85,87,93–105]. 
2.3. Pharmacological inhibitors 
A number of low molecular weight compounds with different 
chemical structures have been found to inhibit ADPR- or H2O2-induced 
Ca2+ responses or ionic currents in cells that express recombinant 
mammalian TRPM2 channels (Table 2), providing useful pharmaco-
logical tools for in vitro and in vivo studies to investigate the role of the 
TRPM2 channel (Table 1). It is worth noting that inhibitors identified in 
earlier studies, including 2-aminoethoxydiphenyl borate (2-APB), N-(p- 
amycinnamoyl) anthranilic acid (ACA), antifungal agents such as clo-
trimazole (CTZ) and econazole and the non-steroidal anti-inflammatory 
flufenamic acid (FFA), while inhibiting the TRPM2 channel with con-
centrations producing a 50% inhibition (IC50) in the range of μM 
(Table 2) [106–111], lack specificity towards the TRPM2 channel [73]. 
8-Br-cADPR, an ADPR analogue, is reported to inhibit the TRPM2 
channel by in vitro [62] and also in vivo studies [112] but, of notice, its 
inhibition has not been consistently observed [113]. Recent studies have 
tested various other ADPR-related analogues for their potential to 
selectively inhibit the TRPM2 channel in vitro [114,115], identifying 
multiple compounds such as 8-phenyl-2′-deoxy-ADPR, 7i and 8a 
(Table 2). A more recent study, by screening a large chemical library, 
has identified JNJ-28583113 as a potent TRPM2 antagonist with an IC50 
of 10–100 nM (Table 2) that protects against TRPM2-mediated effects 
including ROS-induced cell death [116]. JNJ-28583113 was described 
to readily penetrate the blood brain barrier (BBB) but is metabolically 
unstable, limiting its use for in vivo studies. Several divalent cations, 
including Cu2+, Zn2+, Fe2+ and Pb2+, have been shown to act as extra-
cellular TRPM2 inhibitors at micromolar concentrations, with Cu2+
being most potent with an IC50 of 2.6 μM [117–119]. It is worth 
mentioning that additional efforts have been made, focusing on the 
development of cell-permeable peptide inhibitors specific to the TRPM2 
channel, such as tat-M2NX, a peptide corresponding to the NUDT9-H 
domain that is shown to prevent TRPM2 channel activation in vivo as 
well as in vitro [120]. Further efforts are necessary to develop specific, 
potent and metabolically stable TRPM2 inhibitors, particularly 
BBB-penetrable ones, given the increasing recognition of the important 
role of the TRPM2 channel in mediating various pathological conditions 
of the central nervous system (CNS). 
As discussed above, the activity of nuclear PARP, particularly PARP-1, is 
crucial for the induction of ADPR generation and subsequent TRPM2 
channel activation by ROS and other OS-inducing pathological stimuli. 
PARP inhibitors have been used in many studies as an alternative or addi-
tional means to prevent OS-induced TRPM2-mediated effects [36,39,48,74, 
75,82,121–126], including cell death. Example PARP inhibitors include 
SB-750139, N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylace-
tamide (PJ34), 3-aminobenzamide (3-AB) and 3,4-dihydro-5-[4-(1-piperi-
dinyl)butoxy]-1(2H)-isoquinolinone (DPQ). Considering the increasing 
availability of clinically tested and safe PARP inhibitors developed as 
anti-cancer treatments, it is attractive to repurpose PARP inhibitors as po-
tential therapeutics to intervene with OS-induced PARP/TRPM2-mediated 
pathological conditions. 
3. TRPM2 in neuronal cell death associated with ischemia/ 
reperfusion brain damage, AD and PD 
Neurons in the CNS, particularly those in the brain, are highly 
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vulnerable to OS damage. OS-induced neuronal cell death has been 
strongly implicated in the pathogenesis of diverse conditions affecting 
the human brain and cognitive functions, including I/R-induced damage 
and neurodegenerative diseases such as AD and PD. TRPM2 channel 
expression has been documented in neurons in the cortex, hippocampus 
and striatum, the key brain regions in maintaining cognitive functions. 
The role of the TRPM2 channel in mediating OS-induced neuronal cell 
death has been extensively investigated in vitro using primary neuronal 
cultures from rodents and in vivo using rodent models of human diseases 
and conditions. In addition to the use of rodents and neuronal cultures 
derived from them, the role of the TRPM2 channel in OS-induced 
neuronal cell death has been examined using neuroblastoma cell lines, 
especially those of human origin. One such example is SH-SY5Y, a 
human neuroblastoma cell line widely used as a cell model to study the 
molecular mechanisms of neurodegeneration, particularly those related 
to PD [127]. In these studies, OS was introduced by exposure to H2O2 or 
pathological conditions or factors in vitro and in vivo, including I/R, Aβ 
peptides associated with AD pathogenesis, or 1-methyl-4-phenyl-1,2,3, 
6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium ions 
(MPP+) that induce PD-like pathologies. 
3.1. Neuronal cell death induced by exposure to H2O2 
It is well known that exposure to H2O2 imposes OS on neurons under 
in vitro conditions [128,129]. A number of studies have examined the 
role of the TRPM2 channel in mediating H2O2-induced neuronal cell 
death, using primary cortical, hippocampal or striatal neuronal cultures 
from rodents and also human SH-SY5Y cells. Fonfria et al. were the first 
to study the role of the TRPM2 channel in H2O2-induced neuronal cell 
death using rat striatal neurons [75]. Exposure to H2O2 (300 μM for 24 
Table 2 
Chemical structures and IC50 values of TRPM2 channel inhibitors.  
Inhibitor Chemical structure IC50 Reference 
2-APB 1.2 μMa [109] 
ACA 1.7 μMa,b [108] 
Clotrimazole (CTZ) 3-30 uMc [107] 
Econazole 3-30 μMc [107] 
Flufenamic acid (FFA) 70 μMa 
58.3 μMb 
[106,110,111] 
8-Br-cADPR 100 μMd [62] 
7i 5.7 μMa [115] 
8-phenyl-2′-deoxy-ADPR 3 μMa [114] 
8a 5.4 μMa [115] 
JNJ-28583113 13 nMa 
126 nMb 
[116] 
IC50, the concentration of the inhibitor inducing 50% inhibition of ADPR-induced currents a or H2O2-induced Ca2+ responses b; Where IC50 was not determined, 
concentrations showing inhibition of currents induced by ADPR c, cADPR d or H2O2 d in HEK293 cells expressing the human TRPM2 channel. 
P. Malko and L.-H. Jiang                                                                                                                                                                                                                     
Redox Biology 37 (2020) 101755
6
h) resulted in neuronal cell death, measured using SYTOX® Green 
staining. H2O2-induced cell death was decreased in striatal neurons 
transiently transfected with TRPM2-specific small interference RNA 
(TRPM2-siRNA) to reduce TRPM2 expression, or with a plasmid 
expressing TRPM2-S. H2O2-induced cell death in striatal neurons was 
also reduced by treatment with the PARP inhibitor SB-750139 [75]. 
These results suggest that PARP-dependent TRPM2 channel activation 
mediates H2O2-induced neuronal cell death. Another early study re-
ported a similar role for the TRPM2 channel in H2O2-induced cell death 
in cultured rat cortical neurons [130]. In this study, neurons were 
exposed to H2O2 either at a very high concentration (1 mM for 20 min) 
or at a low and pathologically relevant concentration (50 μM for 6 h), 
with both conditions inducing substantial neuronal cell death, detected 
using the trypan blue exclusion method. H2O2-induced neuronal cell 
death was reduced by treatment with TRPM2-siRNA and also by elimi-
nation of extracellular Ca2+, suggesting that TRPM2-mediated Ca2+
influx is crucial for H2O2-induced cell death in cortical neurons. We have 
recently examined H2O2-induced cell death in cultured hippocampal 
neurons from wild-type (WT) and TRPM2-knockout (TRPM2-KO) mice 
and provided further evidence to demonstrate a key role for the TRPM2 
channel in mediating H2O2-induced neuronal cell death [126]. Exposure 
of WT neurons to H2O2 (30–300 μM) for various durations (2–24 h) led 
to concentration-dependent and duration-dependent cell death, deter-
mined using propidium iodide (PI) staining. In contrast, there was 
negligible H2O2-induced cell death in TRPM2-KO neurons. H2O2-in-
duced cell death in WT neurons was also attenuated in the absence of 
extracellular Ca2+ or by treatment with PJ34, supporting the importance 
of PARP-dependent TRPM2 channel activation and subsequent 
TRPM2-mediated Ca2+ signalling in H2O2-induced cell death in hippo-
campal neurons [126], as reported in cortical neurons [130]. In sum-
mary, accumulating evidence consistently supports a critical role for the 
TRPM2 channel and, more specifically, TRPM2-mediated Ca2+
influx-dependent Ca2+ signalling, in mediating H2O2-induced cell death 
in striatal, cortical and hippocampal neurons. 
3.2. Delayed neuronal cell death associated with ischemic stroke and 
other I/R brain damage 
It is known that cerebral ischemia, whether focal as it occurs in 
ischemic stroke or global under cardiac arrest, if severe or long lasting, 
can disrupt neuronal function and induce neuronal demise, whereas 
transient ischemia-induced brain damage can largely be attributed to 
neuronal cell death due to subsequent reperfusion, which is thus spe-
cifically referred to as delayed neuronal cell death [131]. Delayed 
neuronal cell death induced by OS resulting mainly from excessive ROS 
generation during reperfusion is an important cellular mechanism for 
the progressive decline in cognitive function associated with 
I/R-induced brain damage [131–134]. The TRPM2 channel has been 
extensively scrutinised for its role in mediating delayed neuronal cell 
death induced by oxygen-glucose deprivation followed by reoxygena-
tion (OGD/R), an in vitro I/R model, and brain damage and cognitive 
dysfunction by middle cerebral artery occlusion followed by reperfusion 
(MCAO/R), an in vivo model of ischemic stroke, or by bilateral common 
carotid artery occlusion followed by reperfusion (BCCAO/R) or cardiac 
arrest followed by resuscitation (CA-R) [100,105]. 
Two early studies examined the role of the TRPM2 channel in 
delayed neuronal cell death using cultured mouse cortical and hippo-
campal neurons [35,135]. Delayed neuronal cell death, induced by 
exposure to OGD for 2 h followed by reoxygenation for 24 h and 
determined using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium) cell viability assay, was attenuated by treatment with 
2-APB, ACA, FFA or CTZ, introduced during OGD, or by treatment with 
TRPM2-specific short-hairpin RNA (shRNA) to reduce TRPM2 expres-
sion prior to OGD. Consistently, subsequent studies showed that 
OGD/R-induced delayed neuronal cell death was much less severe in 
cultured cortical neurons or in CA1 pyramidal neurons in hippocampal 
slices that were prepared from TRPM2-KO mice [40,136]. In addition, 
OGD/R-induced delayed neuronal death in hippocampal neurons was 
effectively suppressed by treatment with CTZ after re-oxygenation 
[135]. These results suggest a significant role for the TRPM2 channel 
in mediating delayed neuronal cell death. It was noted that genetic or 
pharmacological intervention of the TRPM2 channel inhibited 
OGD/R-induced delayed neuronal cell death in cortical and hippocam-
pal neurons from male mice, but not in those from female mice [35,135], 
suggesting a sexually dimorphic role of the TRPM2 channel in mediating 
delayed neuronal cell death. In contrast, delayed neuronal cell death in 
hippocampal neurons from both male and female mice, induced by 
exposure to H2O2 (50 μM for 2 h) followed by incubation in H2O2-free 
normal culture medium for a further 24 h, was inhibited to a similar 
level by treatment with CTZ applied during exposure to H2O2 [135], 
indicating that the dimorphism may arise from the cellular conditions 
rather than from OS itself. 
Several studies have examined the role of the TRPM2 channel in 
mediating neuronal cell death measured by the number of live neurons 
and brain damage quantified by the infarct size in mice as a consequence 
of cerebral ischemia induced by MCAO/R. In an aforementioned early 
study, it was shown that intra-striatal injection of lentivirus expressing 
TRPM2-specific shRNA to reduce TRPM2 expression, introduced before 
occlusion, protected against MCAO/R-induced neuronal cell death and 
infarction in the striatum [35]. In addition, the infarct size in the cortex, 
striatum and across the entire brain hemisphere in mice subjected to 
MCAO/R, analysed 24 h after reperfusion, was attenuated by adminis-
tration of CTZ during occlusion and again at the time of reperfusion 
[35]. Consistently, several subsequent studies showed independently 
that MCAO/R induced significantly less severe brain damage in 
TRPM2-KO mice as compared to WT mice [37,136,137]. However, there 
was no difference in infarction between WT and TRPM2-KO mice sub-
jected to MCAO without ensuing reperfusion [37]. There was also less 
neuronal cell death in the neocortex of TRPM2-KO mice than that seen in 
WT mice after exposure to MCAO/R [137]. One of these studies showed 
subcutaneous injection of CTZ after reperfusion suppressed 
MCAO/R-induced brain damage in WT mice but was without effect on 
the residual brain damage in TRPM2-KO mice [136]. Similarly, a more 
recent study has reported that MCAO/R-induced infarction in WT mice 
was reduced by injection of the inhibitory tat-M2NX peptide prior to 
ischemia and such a protective effect was absent in TRPM2-KO mice 
[120]. These results are consistent with those from in vitro studies dis-
cussed above and together indicate the protective effects of CTZ and 
tat-M2NX in WT mice via specific targeting of the TRPM2 channel, 
which is in agreement with our finding of exclusive TRPM2 channel 
activation by OS-inducing reperfusion [40]. Collectively, these results 
support an important role for the TRPM2 channel in mediating brain 
damage by reperfusion after transient ischemia, rather than ischemia 
itself. Studies have also examined the role of the TRPM2 channel in 
delayed neuronal cell death and brain damage induced by reperfusion 
following global ischemia. We showed that BCCAO/R induced death of 
pyramidal neurons in the hippocampus CA1 region in male mice and 
impairment in learning and memory, both of which were largely rescued 
by TRPM2-KO [40]. Similarly, death of pyramidal neurons in the hip-
pocampal CA1 region observed in male mice subjected to CA/R was 
suppressed by administration of CTZ after resuscitation [138], a finding 
that also supports the notion that the TRPM2 channel is critical for 
reperfusion-induced neuronal cell death. Of note, as shown for delayed 
neuronal cell death in cultured neurons by in vitro studies, there is evi-
dence to suggest the role of the TRPM2 channel is sexually dimorphic in 
vivo. It has been proposed that sex-dependent differences in the mech-
anisms regulating the TRPM2 channel contribute to such a dimorphism 
[135,136,139,140], but the exact reason remains to be fully established. 
In summary, a number of studies using various in vitro and in vivo I/R 
models have gathered substantial evidence to support a critical role for 
the TRPM2 channel in mediating neuronal cell death due to reperfusion, 
leading to I/R-induced brain damage. Importantly, as discussed above, 
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studies provide a proof of concept that post-ischemia inhibition of the 
TRPM2 channel is a promising therapeutic strategy to mitigate ischemic 
stroke brain damage and cognitive deficits. We will further deliberate in 
detail below the underlying molecular and signalling mechanisms for 
TRPM2-mediated delayed neuronal cell death (Fig. 2A). 
3.3. Aβ-induced neuronal cell death associated with AD 
It is well documented that Aβ peptides, especially Aβ42, found 
plentifully in senile amyloid plaques that represent one of the histo-
pathological hallmarks of human AD brains, are able to induce OS and 
cause neurotoxicity, particularly synapse loss and neuronal cell death, as 
has been posited in the amyloid cascade hypothesis of AD [141,142]. 
Efforts have thus been made to examine the role of the TRPM2 channel 
in mediating Aβ-induced neurotoxicity. In an aforementioned study 
examining H2O2-induced neuronal cell death, Fonfria et al. also showed 
that exposure to Aβ42 (20 μM for 48 h) led to cell death in cultured rat 
striatal neurons [75]. Similar to H2O2-induced neuronal cell death dis-
cussed above, Aβ42-induced neuronal cell death was reduced by treat-
ment with TRPM2-siRNA, overexpression of TRPM2-S or treatment with 
SB-750139, supporting an important role for PARP-dependent TRPM2 
channel activation in Aβ-induced neuronal cell death. The significance 
or relevance of this finding to AD pathogenesis however remained un-
clear, given the extremely high concentration of Aβ42 used. In a more 
recent study using hippocampal neurons, we have shown that exposure 
to Aβ42 at pathologically relevant concentrations (<100 nM-1 μM) for 
various durations (24–96 h) led to concentration-dependent and 
duration-dependent cell death in WT neurons, whereas exposure to 
Aβ42 (1 μM for up to 96 h) induced no or slight cell death in TRPM2-KO 
neurons [82]. In addition, Aβ42-induced cell death in WT neurons was 
attenuated by treatment with 2-APB or ACA and also by treatment with 
PJ34 or DPQ. The study by Ostapchenko et al. showed that neurotox-
icity, indicated by synapse loss and age-related memory impairment, 
was salvaged by TRPM2-KO in APP/PS1 transgenic mice, which are 
widely used in the study of AD pathology due to excessive generation of 
Aβ peptides [42]. These in vitro and in vivo studies provide consistent 
evidence to demonstrate a critical role for the TRPM2 channel in 
Aβ-induced neurotoxicity. In the aforementioned in vitro study using 
cultured hippocampal neurons, we further showed that Aβ42-induced 
neuronal cell death was suppressed by treatment with the protein kinase 
C (PKC) inhibitor Gö6983, generic NOX inhibitors apocynin and 
diphenyleneiodonium (DPI), or NOX1/4-selective inhibitor 
GKT137831. These results suggest that exposure to Aβ42 promotes 
activation of PKC and NOX, and NOX-mediated ROS generation, leading 
to PARP-dependent TRPM2 channel activation and neuronal cell death. 
We will elaborate below the molecular and signalling mechanisms for 
Aβ42-induced TRPM2-mediated neuronal cell death (Fig. 2B). 
3.4. MPTP/MPP+-induced neuronal cell death associated with PD 
The pathological hallmark of PD is the loss of dopaminergic neurons 
in the substantia nigra pars compacta (SNpc) of the human brain that 
gives rise to the disease symptoms [143,144]. MPTP is metabolised to 
MPP+ which, after penetrating the BBB into the brain, is selectively 
accumulated in dopaminergic neurons and induces mitochondrial 
dysfunction and ROS generation causing neurons to die. MPTP/MPP+
are thus known as neurotoxicants generating PD-like pathologies in 
humans, non-human primates and rodents [145]. A recent study has 
shown that TRPM2 protein expression was upregulated in the SNpc of 
human PD brains and the SNpc of MPTP-induced PD mouse brains [44]. 
As mentioned above, human SH-SY5Y cells are widely used in the study 
of the molecular mechanism for PD-related neurodegeneration [127]. 
TRPM2 protein expression was also upregulated in SH-SY5Y cells after 
extended exposure to MPP+ (6–24 h). Consistently, prior MPP+ exposure 
resulted in greater H2O2-induced currents and Ca2+ responses that were 
inhibited by treatment with FFA or ACA, further supporting MPP+-in-
duced upregulation of TRPM2 channel expression. Exposure to H2O2 
(10–400 μM) or MPP+ (125–500 μM) for various durations (2–24 h) 
caused duration-dependent and concentration-dependent cell death in 
SH-SY5Y cells, measured using the MTT assay. MPP+-induced cell death 
was suppressed by treatment with the antioxidant compounds resvera-
trol and N-acetylcysteine (NAC), consistent with the ability of MPP+ to 
induce ROS generation. MPP+-induced cell death was shown to occur 
via apoptosis by annexin V and PI co-staining. Moreover, exposure to 
MPP+ induced upregulation and activation of the Ca2+-sensitive 
Fig. 2. TRPM2-mediated signalling pathways in oxidative stress-induced 
neuronal death associated with ischemia/reperfusion brain damage, AD 
and PD. 
(A) Delayed neuronal cell death associated with ischemia/reperfusion brain 
damage. OS resulting from reperfusion, based on examining H2O2-induced 
delayed neuronal cell death in human neuroblastoma SH-SY5Y cells, stimulates 
activation of PKC and NOX, and NOX-mediated ROS production. ROS induces 
activation of PARP and the TRPM2 channel, and TRPM2-mediated Ca2+ influx. 
ROS also induces lysosomal dysfunction and lysosomal Zn2+ release. TRPM2- 
dependent mitochondrial Zn2+ accumulation leads to mitochondrial dysfunc-
tion and cell death. The cell death mechanisms or pathways are unclear. 
Mitochondrial dysfunction also leads to ROS generation. (B) Aβ42-induced cell 
death in hippocampal neurons associated with AD. Exposure to Aβ42 at path-
ologically relevant concentrations induces a similar signalling pathway as 
described in (A) to cause mitochondrial dysfunction and release of cytochrome 
c. (C) MPP+-induced neuronal cell death related to PD, based on examining 
MPP+-induced cell death in SH-SY5Y cells. Exposure to MPP+ promotes ROS 
generation that activates the TRPM2 channel, likely via PARP, leading to 
intracellular Ca2+ increase, activation of calpain and pro-apoptotic proteins 
(Bak, Bid and Bad), cyt c release, and caspase-3 activation to initiate apoptotic 
cell death. Abbreviations: Aβ, amyloid-β peptide; ADPR, ADP-ribose; AD, Alz-
heimer’s disease; cyt c, cytochrome c; MPP+, 1-methyl-4-phenylpyridinium; 
MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NOX, NADPH oxidase; 
PARP, poly(ADPR) polymerase; PD, Parkinson’s disease; PKC, protein kinase C; 
ROS, reactive oxygen species. 
P. Malko and L.-H. Jiang                                                                                                                                                                                                                     
Redox Biology 37 (2020) 101755
8
protease calpain, pro-apoptotic proteins Bak, Bid and Bad, and 
caspase-3, as well as the release of mitochondrial cytochrome c, indi-
cating that activation of the mitochondria-dependent intrinsic apoptotic 
pathway drives MPP+-induced TRPM2-mediated cell death. 
H2O2/MPP+-induced cell death in SH-SY5Y cells was also attenuated by 
treatment with FFA. Both MPP+-induced cell death and activation of the 
apoptotic pathways were also inhibited by treatment with 
TRPM2-siRNA [44]. In a more recent study using PI staining, we have 
shown that exposure to H2O2 (100–500 μM for 24 h) induced 
concentration-dependent cell death in SH-SY5Y cells and that H2O2-in-
duced cell death was suppressed or abolished by treatment with 2-APB, 
PJ34 or DPQ [123]. Furthermore, by generating a stable SH-SY5Y cell 
line overexpressing the TRPM2 channel and comparing cell death 
following exposure to H2O2 (30–300 μM for 24 h), we further demon-
strated that an increase in TRPM2 channel expression remarkably 
enhanced susceptibility to H2O2-induced cell death [123]. Taken 
together, these studies examining TRPM2 expression in the SNpc of PD 
brains, the SNpc of MPTP-induced PD mouse brains and also 
MPP+-exposed human SH-SY5Y cells, particularly the role of the TRPM2 
channel in H2O2/MPP+-induced cell death in SH-SY5Y cells, suggest that 
PD-related OS induces TRPM2 channel expression upregulation and 
activation, resulting in altered intracellular Ca2+ homeostasis and sub-
sequent activation of calpain and the intrinsic apoptotic pathway 
(Fig. 2C). It is worth mentioning that recent studies have reported that 
microglial cells, the CNS-resident immune cells, undergo cell death after 
exposure to OS induced by H2O2 [146] or MPP+ [147]. Further in-
vestigations are required to examine the role of these TRPM2-mediated 
cell death mechanisms in the pathogenesis of PD. 
3.5. Molecular mechanisms driving OS-induced TRPM2-mediated 
neuronal cell death 
An increasing volume of evidence from in vitro and in vivo studies, as 
discussed above, supports an important role for the TRPM2 channel in 
mediating neuronal cell death and brain damage following exposure to 
diverse notorious OS-inducing pathological factors. It remains relatively 
less well understood how TRPM2 channel activation drives neuronal cell 
death. Studies, by examining various signalling pathways, have pro-
posed distinct mechanisms, and it should be recognised that these 
mechanisms are not necessarily mutually exclusive. 
It is known that the N-methyl-D-aspartate (NMDA)-subtype gluta-
mate receptors (NMDARs) participate in signalling pathways that 
determine neuronal cell death or survival [148–151]. More specifically, 
expression of the GluN2B-containing NMDAR is important in activating 
cell death signalling, whereas expression of the GluN2A-containing 
NMDAR acts as a pro-survival signal through the activation of 
extracellular-regulated kinases (ERK) and Akt. In an aforementioned 
study, Alim et al. showed that TRPM2-KO led to downregulation of 
neuronal GluN2B expression and simultaneous upregulation of neuronal 
GluN2A expression and activation of downstream signalling molecules 
in mice subjected to MCAO/R [37]. These results have led to the pro-
posal that the TRPM2 channel mediates ischemic stroke brain damage 
via modulation of neuronal NMDARs to promote neuronal cell death 
signalling pathways and weaken neuronal cell survival signalling 
pathways [37]. 
It is also well documented that altered intracellular Zn2+ homeostasis 
is a detrimental factor inducing neuronal cell death, particularly 
neuronal death associated with I/R-induced brain damage [94,152, 
153]. In an aforementioned study, we showed that BCCAO/R induced 
intracellular Zn2+ increase and delayed neuronal cell death in CA1 py-
ramidal neurons in the hippocampal region in WT mice, both of which 
were strongly attenuated or lost in TRPM2-KO mice [40]. Furthermore, 
by using time-lapse confocal imaging of intracellular Zn2+ concentration 
in cultured hippocampal neurons during exposure to OGD/R, we 
revealed that TRPM2-KO led to exclusive loss of intracellular Zn2+ in-
crease during reperfusion, without effect on intracellular Zn2+ increase 
during ischemia. These results support the notion that 
reperfusion-induced TRPM2 channel activation alters intracellular Zn2+
homeostasis that triggers delayed neuronal cell death [40]. As described 
above in an early study showing H2O2-induced TRPM2-mediated 
delayed neuronal cell death in cultured mouse hippocampal neurons 
[135], our recent study has shown that H2O2 can induce similar delayed 
cell death in SH-SY5Y cells, with PI staining detecting negligible cell 
death immediately after exposure to H2O2 (100–300 μM for 2 h) but 
substantial cell death after cells were cultured in normal and H2O2-free 
medium for a further 24 h [124]. H2O2-induced delayed cell death in 
SH-SY5Y cells was also mitigated by treatment with PJ34, DPQ, 2-APB 
or ACA, and by removal of extracellular Ca2+, suggesting a critical 
role for PARP-dependent TRPM2 channel activation and subsequent 
TRPM2-mediated Ca2+ signalling in such delayed cell death. Further-
more, H2O2-induced delayed cell death was largely prevented by 
treatment with the Zn2+ chelators TPEN and clioquinol, indicating that 
altered intracellular Zn2+ homeostasis is vital for H2O2-induced delayed 
cell death, as discussed above in delayed neuronal death in hippocampal 
neurons induced by OGD/R in vitro and BCCAO/R in vivo. H2O2-induced 
delayed cell death in SH-SY5Y cells was inhibited by treatment with 
Gö6983, apocynin, DPI or GKT137831, indicating critical involvement 
of PKC/NOX-mediated ROS generation. We further revealed, by 
confocal imaging of the co-localization of Zn2+ indicator FluoZin-3 
staining and intracellular organelle-specific fluorescent indicators, that 
the labile Zn2+ was located in the lysosomes, but not the mitochondria 
or ER under control conditions. Exposure to H2O2 induced lysosomal 
dysfunction indicated by loss of LysoTracker staining, a rise in intra-
cellular Zn2+ concentration by an increase in FluoZin-3 staining, mito-
chondrial Zn2+ accumulation by an increase in mitochondrial Zn2+
indicator RhodZin-3 staining, mitochondrial fragmentation revealed by 
MitoTracker staining, and mitochondrial ROS generation by an increase 
in MitoTracker Red CM-H2Xros staining. These H2O2-induced effects or 
events were all prevented by treatment with PJ34, 2-APB or TPEN, as 
well as apocynin, DPI or GKT137831. Intriguingly, we have found that 
lysosomal dysfunction induced by exposure to bafilomycin also resulted 
in intracellular Zn2+ increase, mitochondrial Zn2+ accumulation, mito-
chondrial fragmentation and mitochondrial ROS generation, all of 
which were also inhibited by treatment with PJ34, 2-APB or TPEN. 
TRPM2 protein was detected in isolated mitochondria, and ADPR 
induced Zn2+ accumulation in isolated mitochondria in the presence but 
not in the absence of Ca2+ [124]. Collectively, these results have led us 
to hypothesise a positive feedback mechanism that drives H2O2-induced 
delayed neuronal cell death in SH-SY5Y cells. As summarised in Fig. 2A, 
such a mechanism is comprised of multiple steps, including initial 
activation of PKC and NOX, NOX-mediated ROS generation, lysosomal 
dysfunction, lysosomal Zn2+ release, TRPM2-dependent mitochondrial 
Zn2+ accumulation, mitochondrial dysfunction and mitochondrial ROS 
generation. 
We have gathered evidence to suggest that a similar vicious positive 
feedback mechanism drives neuronal cell death induced by sustained 
exposure to H2O2 and Aβ42 [82,126]. For example, H2O2-induced cell 
death in cultured hippocampal neurons was inhibited by treatment with 
TPEN [126]. The labile Zn2+ in hippocampal neurons was also mainly 
detected in the lysosomes, but not in the mitochondria or ER under 
control conditions. Exposure to H2O2 induced intracellular Zn2+ in-
crease and, furthermore, lysosomal dysfunction, lysosomal Zn2+ release, 
mitochondrial Zn2+ accumulation, mitochondrial fragmentation and 
mitochondrial ROS generation [126]. Similarly, Aβ42-induced cell 
death in hippocampal neurons was inhibited by treatment with TPEN 
[82]. Exposure to Aβ42 induced lysosomal dysfunction, lysosomal Zn2+
release, mitochondrial Zn2+ accumulation, mitochondrial fragmenta-
tion and mitochondrial ROS generation. These effects induced by H2O2 
and Aβ42 were completely prevented by treatment with TPEN as well as 
by TRPM2-KO. Consistent with the notion that TRPM2 channel activa-
tion is required for mitochondrial Zn2+ accumulation found in SH-SY5Y 
cells, TRPM2 expression and ADPR-induced Ca2+-dependent Zn2+
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accumulation were observed in mitochondria isolated from the hippo-
campus and cortex of WT mouse brains, but ADPR-induced Zn2+ accu-
mulation did not occur in mitochondria isolated from the hippocampus 
and cortex of TRPM2-KO mouse brains [82]. Aβ42-induced lysosomal 
and mitochondrial dysfunction, as well as alteration in intracellular 
Zn2+ homeostasis, was also prevented by treatment with Gö6983, 
apocynin or GKT137831. Moreover, exposure to Aβ42 induced release of 
cytochrome c into the cytosol in hippocampal neurons from WT mice, 
but not from TRPM2-KO. Taken together, these results indicate that 
activation of the TRPM2 channel in mitochondria sets in motion the 
above-described vicious positive feedback mechanism to drive 
Aβ42-induced cell death in hippocampal neurons (Fig. 2B). 
4. TRPM2 in pericyte death associated with neurovascular 
function injury 
Pericytes are critical constituents of a functional and anatomical 
structure called the neurovascular function unit that connects the brain 
parenchyma to the cerebral vasculature, and is crucial in regulating 
cerebral blood flow and maintaining BBB function [154,155]. Loss of 
pericytes and their activity impairs neurovascular function, particularly 
BBB integrity, a mechanism that exacerbates numerous pathological 
conditions in the brain including ischemic stroke and AD [155,156]. It is 
known that ER stress is an important indicator of pericyte dysfunction 
that can itself potentiate cellular damage and induce cell death via 
autophagy [157,158]. Increasing evidence suggests that ultrafine PMs 
with a size of <100 nm commonly present in polluted air and diverse 
NPs widely used in nanomaterials are potent in inducing OS [13,48], ER 
stress and autophagy-mediated cell death [159,160]. We have recently 
examined the role of the TRPM2 channel in mediating zinc oxide-NPs 
(ZnO-NPs)-induced OS, ER stress and autophagy in brain vascular per-
icytes [161]. Exposure of cultured human brain vascular pericytes to 
ZnO-NPs (2.5–20 μg/ml for 6 h) resulted in a concentration-dependent 
increase in the level of LC3-II, indicative of autophagosome formation 
or initiation of autophagy. ZnO-NPs-induced increase in the level of 
LC3-II was prevented by treatment with the selective ER stress inhibitor 
salubrinal, supporting the role of ZnO-NPs-induced ER stress in the 
initiation of autophagy. In addition, ZnO-NPs induced a greater increase 
in the LC3-II level in pericytes treated with chloroquine to inhibit con-
version of the autophagosome to an autolysosome and thereby stop 
autophagic flux. It is known that an acidic environment can quench the 
fluorescence of green fluorescent protein (GFP) but not that of red 
fluorescent protein (RFP), and expression of the tandem mRFP-GFP-LC3 
protein followed by fluorescent imaging is widely used to probe auto-
phagic flux in cells in vitro and in vivo [162]. We demonstrated by 
confocal imaging of pericytes expressing a mRFP-GFP-LC3 construct 
that exposure to ZnO-NPs enhanced autophagosome formation, indi-
cated by an increase in the number of yellow puncta (emitting both RFP 
and GFP fluorescence), and also autolysosome formation, by an increase 
in the number of red puncta (due to quenching of GFP fluorescence by 
the acidic pH of autolysosomes). ZnO-NPs-induced effects on the level of 
LC3-II in control or chloroquine-treated cells were reduced by treatment 
with TRPM2-siRNA, suggesting an important role for the TRPM2 
channel in ZnO-NPs-induced initiation of autophagy and increase in 
autophagic flux. We also showed using TUNEL staining, cell counting 
kit-8 cell viability assay or PI staining that exposure to ZnO-NPs (10 
μg/ml for 6 h) induced cell death via apoptosis, which was suppressed by 
treatment with TRPM2-siRNA and also by siRNA-mediated knockdown 
of AGT5, a key autophagy-mediating protein. In addition, exposure to 
ZnO-NPs induced caspase-8 activation, which was also attenuated by 
treatment with TRPM2-siRNA or ATG5-siRNA. These results indicate 
that ZnO-NPs-induced TRPM2 channel activation triggers 
autophagy-mediated apoptotic cell death. Furthermore, we showed that 
exposure to ZnO-NPs (10 μg/ml for 2–24 h) resulted in a time-dependent 
increase in the levels of CHOP and phosphorylation of PERK and c-Jun 
N-terminal kinase (JNK), which are known to be critically involved in 
ER stress signalling. ZnO-NPs-induced ER stress signalling was attenu-
ated by treatment with TRPM2-siRNA. Collectively, these results sup-
port the importance of the TRPM2 channel in mediating 
ZnO-NPs-induced ER stress signalling and subsequent induction of 
autophagy and apoptotic cell death in pericytes [161]. Exposure to 
ZnO-NPs induced pericytes to generate peroxynitrite, which was 
inhibited by treatment with the peroxynitrite scavenger uric acid (UA). 
ZnO-NPs-induced ER stress indicated by an increase in the levels of 
CHOP and JNK activation, autophagy by the increase in the level of 
LC3-II, and apoptotic cell death were suppressed by treatment with UA, 
the nitric oxide synthase (NOS) inhibitor N(G)-nitro-L-arginine methyl 
ester (L-NAME) or in combination. These results suggest that ZnO-NPs 
induce oxidative and nitrosative stress to cause ER stress and auto-
phagy, triggering apoptosis in pericytes. In HEK293 cells expressing the 
human TRPM2 channel, exposure to ZnO-NPs (10 μg/ml) or the per-
oxynitrite donor 3-morpholinosydnonimine (SIN-1; 0.5 mM) attenuated 
ADPR-induced currents, which were rescued by treatment with UA or 
L-NAME. In contrast, exposure to ZnO-NPs or SIN-1 induced no effect on 
ADPR-induced current response in HEK293 cells expressing a mutant 
channel, in which the nitration site Tyr1485 in the intracellular C-ter-
minus was mutated to serine (Y1485S). Consistently, both the increase 
in the levels of CHOP and activation of PERK and JNK (ER stress) and the 
increase in the level of LC3-II (autophagy) induced by exposure to 
ZnO-NPs or peroxynitrite were significantly attenuated in pericytes 
overexpressing the Y1485S mutant channel. These results have led to the 
notion that upregulation of TRPM2 channel activity as a result of 
nitration at Tyr1485 enhances ER stress and autophagy-mediated 
apoptosis in human pericytes (Fig. 3). In mice, introduction of 
ZnO-NPs (0.1 ml of 0.5 mg/ml) via tail vein injection induced loss of 
pericytes in the brain micro-vessels, assessed 24 h post-injection by 
double labelling of α-smooth muscle actin (α-SMA), a commonly used 
marker of pericytes, and laminin in vascular-specific basal membrane 
followed by confocal imaging [161]. Exposure to ZnO-NPs also resulted 
in increased autolysosome formation indicated by an increase in the 
number of red puncta in α-SMA-positive pericytes in micro-vessels, 
revealed by confocal imaging of the cortex of mice prior injected with 
adenovirus expressing the mRFP-GFP-LC3 reporter. ZnO-NPs-induced 
autophagy and loss of brain pericytes were attenuated in TRPM2-KO 
mice [161]. Taken together, these results from in vitro experiments on 
human brain vascular pericytes and in vivo studies using WT and 
TRPM2-KO mice provide consistent evidence to support an important 
role for the TRPM2 channel in mediating autophagy-mediated apoptotic 
cell death in brain vascular pericytes as a result of exposure to patho-
logical stimuli inducing OS and ER stress (Fig. 3). 
Fig. 3. TRPM2-mediated signalling pathways in oxidative stress-induced 
pericyte death associated with neurovascular injury induced by expo-
sure to nanoparticles. 
Exposure to ZnO-NPs increases ROS generation to induce TRPM2 channel 
activation, possibly via PARP and also generation of peroxynitrite for TRPM2 
nitration to upregulate the channel activity in pericytes. TRPM2 channel acti-
vation leads to intracellular Ca2+ increase and ER stress that induces autophagy 
and caspase-8 activation to cause pericyte death by apoptosis. Abbreviations: 
ADPR, ADP-ribose; ER, endoplasmic reticulum; PARP, poly(ADPR) polymerase; 
ROS, reactive oxygen species; ZnO-NPs, zinc oxide nanoparticles. 
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5. TRPM2 in cardiomyocyte death associated with myocardial I/ 
R injury 
Myocardial injury induced by reperfusion contributes to adverse 
cardiovascular outcomes after myocardial ischemia or cardiac arrest. 
OS, resulting from ROS generation mainly by mitochondria and also 
mediated by NOX, is one of the major causes of I/R-induced car-
diomyocyte death and myocardial injury [24–27]. An early in vitro study 
examined the role of the TRPM2 channel in mediating H2O2-induced cell 
death in cultured neonatal rat ventricular myocytes [163]. H2O2 
(10–500 μM exposure for 1 h) concentration-dependently induced an 
increase in cell membrane permeabilisation assessed by PI staining and a 
reduction in intracellular ATP level measured immediately after expo-
sure and, in addition, nuclear chromatin condensation shown by 
Hoechst staining of cells after incubation in normal and H2O2-free me-
dium for a further 4.5 h. More specifically, in response to exposure to 
H2O2 (100 μM for 1 h), marked activation of caspase-3 was detected at 
20 min, a reduction in intracellular ATP level at 40 min, an increase in PI 
staining at 1 h, and chromatin condensation after cells were cultured in 
the absence of H2O2 for a further 2 h. These results suggest that 
H2O2-induced OS causes cardiomyocytes to die via both apoptosis and 
necrosis, both of which are known to contribute to myocardial I/R 
injury. Exposure to H2O2 (100 μM for 1 h) also induced cytochrome c 
release and caspase-3 activation examined immediately after exposure, 
and DNA fragmentation revealed by TUNEL staining as well as chro-
matin condensation in cells after culturing in the absence of H2O2 for a 
further 4.5 h. H2O2-induced chromatin condensation and DNA frag-
mentation were attenuated by treatment with the caspase-3 inhibitor 
z-DEVD-FMK, supporting caspase-3-dependent apoptotic cell death. 
H2O2-induced chromatin condensation was also reduced by treatment 
with the mitochondrial Ca2+ uniporter (MCU) inhibitor RU360 or 
removal of extracellular Ca2+, and completely abolished by removal of 
both extracellular Ca2+ and Na+. Exposure to H2O2 (100 μM) induced 
increases in intracellular Ca2+ and Na+ concentrations that were pre-
vented by treatment with CTZ. H2O2-induced cytochrome c release, 
caspase-3 activation, chromatin condensation and DNA fragmentation 
were attenuated by treatment with CTZ. H2O2-induced intracellular 
Ca2+ increase, chromatin condensation and DNA fragmentation were 
inhibited but only partially by treatment with 3-AB or DPQ. Collectively, 
these results suggest ROS induces cardiomyocyte apoptosis, mediated by 
a molecular mechanism which is composed of activation of PARP and 
the TRPM2 channel, TRPM2-mediated extracellular Ca2+ and Na+ influx 
and MCU-mediated mitochondrial accumulation of Ca2+ and Na+, 
leading to mitochondrial dysfunction, cytochrome c release and 
caspase-3 activation (Fig. 4A). In contrast, H2O2-induced membrane 
permeabilisation was not affected by treatment with CTZ, but almost 
completely abolished by treatment with 3-AB or DPQ, leading to the 
notion that H2O2-induced necrotic cell death results from 
PARP-dependent but TRPM2-indepdent depletion of ATP [163] 
(Fig. 4A). As mentioned above, CTZ has limited selectivity towards the 
TRPM2 channel and thus further studies using more specific pharma-
cological or genetic interventions are required to elaborate the role of 
the TRPM2 channel in ROS-induced neonatal cardiomyocyte death. 
It is known that the proinflammatory cytokine TNF-α contributes to 
the exacerbation of myocardial I/R injury by inflammation via the in-
duction of mitochondrial dysfunction and alteration in intracellular 
Ca2+ homeostasis in cardiomyocytes [164]. A recent study has exam-
ined, using ventricular myocytes isolated from adult mice, the TRPM2 
channel in mediating TNF-α-induced cardiomyocyte death in relation to 
myocardial I/R injury [165]. Exposure to TNF-α (10 ng/ml for 1 h) 
induced mitochondrial ROS generation shown using MitoSOX Red, 
which was attenuated by treatment with the caspase-8 inhibitor 
z-IETD-FMK, indicating caspase-8-dependent mitochondrial ROS pro-
duction. Prolonged exposure to TNF-α (10 ng/ml for up to 4 h) induced a 
cationic current that was reduced by treatment with NAC as well as 
z-IETD-FMK. TNF-α-induced current was abolished or reduced by 
treatment with 2-APB, CTZ, ACA, FFA or 3-AB. Exposure to H2O2 (100 
μM) or application of intracellular cADPR (100 μM) evoked a similar 
cationic current that was reduced by treatment with 2-APB or CTZ. In 
addition, exposure to TNF-α for 4 h induced poly(ADPR) polymer for-
mation. Together, these results support that TNF-α induces TRPM2 
channel activation, dependent on ROS generation and PARP activation. 
In response to exposure to TNF-α, there was an initial increase in 
intracellular Ca2+ concentration followed by cell death detected by PI 
staining. Both the TNF-α-induced initial Ca2+ response and subsequent 
cell death were largely prevented by treatment with CTZ or an 
anti-TRPM2 blocking antibody [165]. These results in combination 
suggest that TNF-α induces cardiomyocyte death via caspase-8 
Fig. 4. TRPM2-mediated signalling pathways in oxidative stress-induced 
cardiomyocyte death associated with myocardial ischemia/reperfusion 
injury. 
(A) H2O2-induced neonatal cardiomyocyte death. Exposure to H2O2 induces 
apoptotic cell death via activation of PARP and the TRPM2 channel, TRPM2- 
mediated Na+ and Ca2+ influx and subsequent MCU-mediated mitochondrial 
Na+ and Ca2+ overloading, leading to mitochondrial dysfunction, cyt c release 
and caspase-3 activation to initiate apoptotic cell death. Exposure to H2O2 also 
induces necrotic cell death as a result of PARP-dependent and TRPM2- 
indpendent depletion of ATP. (B) TNF-α-induced adult cardiomyocyte death. 
Exposure to TNF-α induces caspase-8-dependent mitochondrial ROS generation, 
activation of PARP and the TRPM2 channel, TRPM2-mediated Ca2+ influx and 
cell death via unknown mechanism(s). (C) TRPM2 channel activation in adult 
cardiomyocytes has been proposed to play an opposing role by protecting 
against cardiomyocyte death induced by H2O2 or myocardial I/R. TRPM2- 
mediated Ca2+ influx activates Ca2+-dependent PYK2 kinase and ERK1/2 and 
Akt, downstream pro-survival signalling. PYK2 is also translocated to mito-
chondria and upregulates MCU function and MCU-mediated Ca2+ into mito-
chondria to maintain mitochondrial function and reduce mitochondrial ROS 
generation. Abbreviations: ADPR, ADP-ribose; cyt c, cytochrome c; ERK, extra-
cellular signal-regulated kinase; MCU, mitochondrial Ca2+ uniporter; PARP, 
poly(ADPR) polymerase; PYK2, proline-rich tyrosine kinase 2; ROS, reactive 
oxygen species; TNF-α, tumour necrosis factor-α. 
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activation, mitochondrial ROS generation, activation of PARP and the 
TRPM2 channel, and TRPM2-mediated Ca2+ signalling (Fig. 4B). 
Hiroi et al. examined the role of the TRPM2 channel in I/R-induced 
cardiomyocyte death and myocardial injury in vivo using a mouse 
myocardial I/R model [166]. Exposure to ischemia for 45 min followed 
by reperfusion for 24 h led to considerable infarction in the myocardium 
of WT mice, which was reduced in TRPM2-KO mice. Myocardial 
I/R-induced increase in the plasma levels of troponin I, a marker of 
myocardial injury, measured 2 h post-reperfusion, was also reduced by 
TRPM2-KO. However, ischemia with various durations (45 min–24 h) 
without ensuing reperfusion resulted in a duration-dependent increase 
in infarct size that was comparable between WT and TRPM2-KO mice, 
suggesting exclusive involvement of the TRPM2 channel in 
reperfusion-induced myocardial injury, as reported for the TRPM2 
channel in I/R-induced brain damage discussed above. Neutrophils are 
known to infiltrate the myocardium as a prominent inflammatory 
component of post-ischemic injury and an important source of proin-
flammatory mediators such as TNF-α and ROS contributing to myocar-
dial I/R-induced injury. Neutrophil infiltration after myocardial I/R was 
attenuated in TRPM2-KO mice compared with that in WT mice. To 
elaborate the contribution of the TRPM2 channel in cardiomyocytes and 
infiltrating neutrophils in myocardial I/R injury, isolated hearts from 
WT and TRPM2-KO mice were perfused with polymorphonuclear leu-
cocytes (PMNs) of each genotype before being subjected to ischemia via 
regional coronary ligation for 1 h followed by reperfusion for 2 h. 
I/R-induced infarction was less in WT hearts perfused with TRPM2-KO 
PMNs than with WT PMNs. The infarct size in TRPM2-KO hearts 
perfused with TRPM2-KO PMNs was smaller than that in TRPM2-KO 
perfused with WT PMNs. Moreover, the infarct size in TRPM2-KO 
hearts infused with WT PMNs was decreased by treatment with econa-
zole. While the infarct size in WT mice with intravenous administration 
of TRPM2-KO PMNs, induced by ischemia for 45 min followed by 
reperfusion 2 h, was slightly but insignificantly attenuated compared to 
that in WT mice with WT PMNs, the infarct size in TRPM2-KO mice 
administrated with TRPM2-KO PMNs was smaller than in TRPM2-KO 
with WT PMNs. Furthermore, the maximal left ventricular pressure in 
TRPM2-KO mice was higher than that in WT mice after exposure to 
myocardial I/R, indicating that TRPM2 deficiency offers a protective 
effect on cardiac contractile function. These results support an impor-
tant role for the TRPM2 channel, particularly the TRPM2 channel in 
neutrophils, in mediating myocardial I/R injury [166]. Overall, the 
findings from these in vitro and in vivo studies support the TRPM2 
channel as an important molecular mechanism mediating I/R-induced 
cardiomyocyte death and myocardial injury. 
Miller and colleagues provide evidence, however, that favours an 
opposing role of the TRPM2 channel in cardiomyocytes, namely, that the 
TRPM2 channel protects against ROS-induced cardiomyocyte death and 
myocardial I/R injury and thereby preserves cardiac function [96, 
167–170]. As shown in an earlier study using ventricular myocytes 
isolated from adult mice [169], exposure to H2O2 (200 μM) increased 
intracellular Ca2+ concentration that was dependent on extracellular 
Ca2+ and reduced by treatment with CTZ. Such H2O2-induced Ca2+
response was smaller in myocytes isolated from TRPM2-KO mice. These 
results are overall similar to those reported in earlier studies by other 
groups using neonatal or adult ventricular myocytes [163,165], sup-
porting a key role for the TRPM2 channel in mediating ROS-induced 
Ca2+ signalling in cardiomyocytes. However, the area at risk and 
infarct size were similar in hearts of WT and TRPM2-KO mice after 
exposure to ischemia for 30 min followed by reperfusion for 3 days. 
There was also no difference in I/R-induced reduction in systolic intra-
cellular Ca2+ concentration and maximal contraction amplitude in 
myocytes from WT and TRPM2-KO mice. Nonetheless, both fractional 
shortening and the maximal first time derivative of the left ventricular 
pressure rise (+dP/dt), assessed on days 2–3 after myocardial I/R, were 
lower in TRPM2-KO hearts than in WT hearts, indicating TRPM2 defi-
ciency worsens heart contractility. The expression of proteins that are 
important for excitation-contraction coupling was differentially altered 
in WT and TRPM2-KO mice after myocardial I/R, with the level of 
Na+/Ca2+ exchanger elevated and the level of Na+-K+-ATPase α1-sub-
unit decreased in hearts from TRPM2-KO mice compared to WT mice. In 
addition, the action potential duration was prolonged in cardiomyocytes 
from TRPM2-KO mice relative to WT mice after exposure to myocardial 
I/R. Furthermore, ROS generation was higher in TRPM2-KO myocytes 
than in WT myocytes after exposure to hypoxia for 2 h followed by 
reoxygenation for 30 min. Consistently, the expression levels of super-
oxide dismutase 1 (SOD1) and SOD2, ROS-scavenging enzymes, and 
hypoxia-inducible factor-1α and forkhead box transcription factors, 
FoxO1 and FoxO3a, upstream regulators of SOD expression, were 
attenuated, whereas the NOX4 expression level was higher in hearts 
from TRPM2-KO mice exposed I/R. These results led to the conclusion 
that TRPM2 channel activation is protective against myocardial I/R 
injury by enhancing the ROS-scavenging capacity to reduce I/R-induced 
OS [169]. As reported in a subsequent study, exposure to myocardial I/R 
induced greater mitochondrial dysfunction in TRPM2-KO hearts than in 
WT hearts, suggesting a role for the TRPM2 channel in preserving 
mitochondrial function and thereby preventing mitochondrial ROS 
generation in cardiomyocytes [168]. Mice deficient in cardiac-specific 
TRPM2 expression, while showing similar I/R-induced infarction in 
the heart as WT mice, exhibited significantly reduced myocardial per-
formance [167]. This study provided further evidence by expressing the 
mutant TRPM2 channel with impaired Ca2+ permeability in car-
diomyocytes to show that TRPM2-mediated Ca2+ influx into car-
diomyocytes is critical in the maintenance of mitochondrial function 
and protection against myocardial I/R injury. Moreover, as shown in a 
more recent study [170], exposure to H2O2 (200 μM for 15 min) 
increased the phosphorylation levels of the Ca2+-sensitive proline-rich 
tyrosine kinase PYK2, and downstream pro-survival signalling mole-
cules ERK1/2 and Akt in WT adult mouse cardiomyocytes, which was 
attenuated by TRPM2-KO and also by treatment with the intracellular 
Ca2+ chelator BAPTA-AM. In addition, exposure to H2O2 promoted the 
translocation of PYK2 from the cytosol to mitochondria in WT adult 
mouse cardiomyocytes. Exposure to myocardial I/R also elevated the 
levels of phosphorylation or activity of PYK2, ERK1/2 and Akt in WT 
hearts, which were attenuated in TRPM2-KO hearts. Furthermore, 
exposure to hypoxia for 30 min followed by reoxygenation for 30 min 
induced a greater level of mitochondrial ROS generation in TRPM2-KO 
myocytes than in WT myocytes. It has been proposed, therefore, that 
OS-induced TRPM2 channel activation protects against I/R-induced 
cardiomyocyte death and myocardial injury by a molecular and sig-
nalling mechanism, including TRPM2-mediated Ca2+ influx, 
Ca2+-dependent activation of PYK2 and subsequent activation of 
ERK1/2 and Akt and, in addition, translocation of PYK2 into mito-
chondria to upregulate the MCU function and MCU-mediated Ca2+ entry 
into the mitochondria to maintain mitochondrial function and reduce 
mitochondrial ROS generation (Fig. 4C). 
It is clear that there are substantial discrepancies in the molecular 
and cellular mechanisms mediated by the TRPM2 channel and therefore 
it remains a matter of debate and further investigation whether the 
TRPM2 channel plays a beneficial or harmful role in myocardial I/R 
injury. Such a dichotomy in the role of the TRPM2 channel or TRPM2- 
mediated Ca2+ signalling in terms of cardiomyocyte function may be 
attributable to various factors [96], including the use of cardiomyocytes 
from mice of different ages (neonate versus adult), different experi-
mental conditions and assessment methods, particularly different I/R 
models that are well known to be important in the study of myocardial 
I/R-induced injury and cardiovascular outcomes [171]. As such, further 
efforts with rigour and reproducibility in the design and execution of 
experiments and analysis of data may be required to clarify the physi-
ological or pathological role of the TRPM2 channel in myocardial I/R 
injury. 
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6. TRPM2 in endothelial cell death associated with vascular 
dysfunction and cardiovascular diseases 
Endothelial cells that line the interior surface of blood vessels are 
particularly susceptible to OS, mainly resulting from ROS production by 
neutrophils and other PMNs as well as by endothelial cells themselves 
[172]. It is well known that OS-induced vascular endothelial dysfunc-
tion plays a significant role in the pathophysiology of multiple cardio-
vascular diseases, including I/R injury, hypertension, heart failure, 
diabetes, pulmonary inflammation and atherosclerosis [23,24,28, 
173–179]. Hecquet et al. were the first to examine endothelial expres-
sion of the TRPM2 channel using human pulmonary artery endothelial 
cells [74]. Exposure to H2O2 (300 μM) elicited an inward cationic cur-
rent that was attenuated by treatment with TRPM2-siRNA or with DPQ. 
Consistently, exposure to H2O2 (25–300 μM) induced a 
concentration-dependent increase in intracellular Ca2+ concentration, 
which was dependent on extracellular Ca2+. H2O2-induced Ca2+
response was inhibited by treatment with TRPM2-siRNA or an 
anti-TRPM2 blocking antibody, by overexpression of TRPM2-S, and by 
treatment with 3-AB or DPQ. These results support functional expression 
of the TRPM2 channel and PARP-mediated activation by ROS [74]. The 
study further showed a significant role for the TRPM2 channel in 
mediating H2O2-induced endothelial barrier dysfunction [74]. A sepa-
rate study by Wang et al. reported that TRPM2-mediated Ca2+ signalling 
in endothelial cells plays an important role in coupling ultrafine 
PMs-induced ROS generation to activation of calpain and subsequent 
degradation of zonula occludens tight junction proteins to impair 
endothelial barrier function [180]. 
Sun et al. examined the role of the TRPM2 channel in mediating OS- 
induced endothelial cell death using H5V, a mouse endothelial cell line 
[181]. Exposure to 3 mM H2O2 resulted in a cationic current and Ca2+
influx, both of which were attenuated by treatment with TRPM2-shRNA 
or an anti-TRPM2 blocking antibody. Exposure to H2O2 (156–2500 μM 
for 1 h) resulted in a significant and concentration-dependent reduction 
in cell viability, measured using the MTT assay, which was attenuated by 
treatment with TRPM2-shRNA. The activity of caspase-3 and caspase-8 
was elevated and the level of pro-caspase-9 was reduced in cells after 
exposure to H2O2 (3 mM for 6 h), and DNA fragmentation, and nuclear 
condensation and fragmentation was observed in cells after exposure to 
H2O2 (3 mM for 24 h). All of these effects were reduced by treatment 
with TRPM2-shRNA or an anti-TRPM2 blocking antibody. As shown in 
the same study, exposure to TNF-α (10 ng/ml for 36 h), which is pro-
posed to induce ROS production and mediate endothelial cell apoptosis 
with a potential role in atherosclerosis development [182], reduced cell 
viability assessed using the MTT assay, which was attenuated by treat-
ment with TRPM2-shRNA or an anti-TRPM2 blocking antibody [181]. 
These results support that OS, as a result of exposure to H2O2 or 
TNF-α-induced ROS generation, induces TRPM2 channel activation, 
leading to caspase-dependent apoptosis and thereby a reduction in 
endothelial cell viability (Fig. 5A). A recent study by Hecquet et al. has 
confirmed the role of the TRPM2 channel in H2O2-induced apoptosis in 
human pulmonary artery endothelial cells [77]. Exposure to H2O2 
(25–300 μM for 24 h) caused a concentration-dependent increase in 
apoptotic cells detected by staining with annexin V-phycoerythrin and 
7-aminoactinomycin D. Exposure to glucose oxidase (GO) together with 
glucose for 1.5 h, which is known to induce H2O2 generation, also 
induced endothelial cells to undergo apoptosis. Apoptotic cell death 
induced by both H2O2 and GO was attenuated by treatment with an 
anti-TRPM2 blocking antibody or TRPM2-siRNA. Perfusion of WT mice 
with H2O2 (300 μM) or GO (1–2.5 mU/mL) for 75 min caused apoptosis 
of endothelial cells in lung vessels, assessed by immunostaining of 
vascular endothelial-cadherin and cleaved-PARP due to activation of 
apoptosis-associated caspases, 3 h after perfusion with H2O2 or GO. 
Consistently, perfusion with H2O2 or GO resulted in caspase-3 activation 
and PARP cleavage in the lung tissue. These effects induced by H2O2 or 
GO were attenuated or prevented in the lungs of TRPM2-KO mice. As 
shown in human pulmonary artery endothelial cells, endothelial cells 
express both full-length TRPM2 and TRPM2-S isoforms. Interestingly, 
TRPM2-S interacted with TRPM2 and also with PKCα, shown by 
co-immunoprecipitation. Exposure to H2O2 (300 μM for up to 5 min) led 
to phosphorylation of TRPM2-S and PKCα, and also an increase in their 
interaction; both H2O2-induced phosphorylation and interaction of 
these two proteins were largely prevented by treatment with Gö6976, or 
the PKCα inhibitor peptide PKCαi, as well as by treatment with 
TRPM2-siRNA and PKCα-siRNA. Ca2+ influx-dependent intracellular 
Ca2+ increase induced by exposure to H2O2 (100 μM) was also attenu-
ated by treatment with Gö6976, PKCαi, PKCα-siRNA or TRPM2-siRNA. 
Furthermore, H2O2-induced phosphorylation and interaction of 
TRPM2-S and PKCα, and Ca2+ response were abolished by over-
expression of TRPM2-S with the phosphorylation site Ser39 mutated to 
alanine. Exposure to H2O2 (100 μM for up to 5 min) induced rapid 
dissociation of TRPM2-S from TRPM2. H2O2-induced dissociation of 
TRPM2-S and TRPM2 and also H2O2/GO-induced apoptotic cell death 
were attenuated by treatment with Gö6976 or PKCαi, or overexpression 
of TRPM2-S carrying the S39A mutation. H2O2-induced 
TRPM2-mediated Ca2+ influx and apoptotic cell death were reduced in 
endothelial cells from PKCα-KO mice. These results support a novel 
mechanism, by which TRPM2-S inhibits the TRPM2 channel and its role 
in mediating ROS-induced apoptosis in endothelial cells (Fig. 5B). 
TRPM2-S forms a complex with the TRPM2 channel under resting con-
ditions. ROS activate PKCα that in turn interacts with TRPM2-S and 
phosphorylates Ser39, resulting in dissociation of TRPM2-S from the 
TRPM2 channel and loss of the inhibition, and ROS also activate PARP 
and the TRPM2 channel, inducing TRPM2-mediated Ca2+ influx to 
trigger apoptotic cell death (Fig. 5B). To illustrate the pathophysiolog-
ical significance of such a molecular and cellular mechanism, endothe-
lial cell apoptosis in mouse lungs and survival were examined in mice 
after intraperitoneal injection with lipopolysaccharide (LPS), a bacterial 
Fig. 5. TRPM2-mediated signalling pathways in oxidative stress-induced 
endothelial cell death associated with endothelial barrier dysfunction 
and vascular diseases. 
Two distinctive but overlapping signalling mechanisms mediate H2O2-induced 
endothelial death. (A) Exposure to H2O2 induces apoptotic cell death via acti-
vation of PARP and the TRPM2 channel, TRPM2-mediated Ca2+ influx and 
subsequent activation of caspase-3, caspase-8 and caspase-9 activation to 
initiate apoptotic cell death. Exposure to TNF-α also induces apoptotic cell 
death through the same signalling mechanism. (B) Exposure to H2O2 also in-
duces PKCα activation, which in turn phosphorylates TRPM2-S and promotes 
dissociation of TRPM2-S with, and releases its inhibition of, the TRPM2 chan-
nel, resulting in increased TRPM2-mediated Ca2+ influx and caspase-3 activa-
tion. ROS generation by GO in the presence of glucose induces endothelial cell 
death via the signalling mechanisms presented in (B). Abbreviations: ADPR, 
ADP-ribose; GO, glucose oxidase; PARP, poly(ADPR) polymerase; PKCα, protein 
kinase Cα; ROS, reactive oxygen species; TNF-α, tumour necrosis factor-α. 
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endotoxin known to produce ROS in endothelial cells. Endothelial cell 
apoptosis in the lungs, determined 4 h after injection of LPS by staining 
frozen lung tissues with a vascular endothelial-cadherin antibody and 
TUNEL, was observed in WT mice, but largely eliminated in PKCα-KO or 
TRPM2-KO mice that were prior transplanted with bone marrow cells 
from WT mice to restore the expression of PKCα or TRPM2 in immune 
cells. Consistently, the survival rate during the 96 h following LPS in-
jection was significantly improved in TRPM2-KO and PKCα-KO chimeric 
mice compared to WT mice. Overall, these results suggest that 
OS-induced apoptotic cell death leads to endothelial dysfunction and 
increases the susceptibility to lung inflammation and damage. These 
findings gain further support from a more recent study by the same 
group using tamoxifen-inducible endothelial cell-specific conditional 
TRPM2-KO mice [183]. Endothelial cell-specific TRPM2-KO mice had a 
survival rate of 80%, in contrast with the survival of no WT mice, 96 h 
after intraperitoneal injection with LPS. Moreover, compared to WT 
mice, endothelial cell-specific TRPM2-KO mice had significantly lower 
myeloperoxidase activity at 6 and 24 h following treatment with LPS, 
and exhibited reduced infiltration of PMNs into lung tissues. It was 
further shown that PMNs-derived ROS generation is sufficient in 
inducing TRPM2-mediated increase in intracellular Ca2+ concentration 
in endothelial cells to trigger endothelial barrier dysfunction and 
trans-endothelial migration of PMNs [183]. It remains unclear whether 
such PMNs-derived ROS-induced TRPM2 channel activation results in 
endothelial cell apoptosis. In summary, studies have so far provided 
clear evidence to support an important role for the TRPM2 channel or 
TRPM2-mediated Ca2+ signalling in OS-induced endothelial cell death 
and endothelial barrier dysfunction, leading to increased extravasation 
of PMNs and vascular inflammation, a mechanism with potential sig-
nificance in the pathophysiology of vascular diseases. 
7. TRPM2 in pancreatic cell death associated with diabetes and 
acute biliary pancreatitis 
7.1. H2O2/STZ-induced pancreatic β-cell death associated with diabetes 
Pancreatic β-cells make up 50–70% of the cells in human islets and 
are responsible for the generation of insulin. Insulin insufficiency due to 
loss of pancreatic β-cells and impairment of their function leads to 
hypoinsulinemia and hyperglycaemia or diabetes [184]. It is well rec-
ognised that pancreatic β-cells are weak in their antioxidant capacity 
and thus known to be highly susceptible to OS damage [185]. Strepto-
zotocin (STZ) has the ability to induce ROS generation as well as DNA 
damage and therefore is used clinically as a chemotherapeutic agent in 
the treatment of pancreatic β-cell carcinoma, and is also used experi-
mentally as a diabetogenic agent to induce diabetes-like pathologies in 
rodents [186]. It is worth mentioning that activation of nuclear PARP-1 
is long known to be critical in mediating STZ-induced loss of pancreatic 
β-cells and diabetes in rodents [187,188]. An early study reported 
functional expression of a molecularly unidentified Ca2+-permeable 
channel, which is known as TRPM2 today, that mediated H2O2-induced 
Ca2+ signalling and cell death in CRI-G1, a rat insulin-secreting cell line 
[189]. A number of studies, using various insulin-secreting cell lines, 
rodent and human islets, and mouse models of diabetes, have examined 
the role of PARP-dependent TRPM2 channel activation in mediating 
pancreatic β-cell death induced by H2O2 or stimuli known to induce OS, 
with particular interest in the pathogenesis of both type 1 and type 2 
diabetes (T1D and T2D). Ishii et al. showed that exposure to H2O2 (100 
μM) elevated intracellular Ca2+ concentration in RIN-5F, a rat 
insulin-secreting pancreatic islet tumour cell line, which was attenuated 
by treatment with 3-AB or PJ34 [39]. In addition, exposure to H2O2 
(300 μM for up to 4 h) induced cell death, shown using the trypan blue 
exclusion method. The onset of H2O2-induced cell death was delayed by 
treatment with 3-AB, and H2O2-induced cell death was attenuated by 
treatment with 3-AB or PJ34 [39]. Similarly, we showed using PI 
staining that exposure to H2O2 (200 μM for 2 h) resulted in cell death in 
INS-1 cells, an insulin-secreting β-cell line derived from a rat insulinoma, 
which was attenuated by treatment with PJ34 or 2-APB, supporting that 
PARP-dependent TRPM2 channel activation mediates H2O2-induced cell 
death [36]. H2O2-induced cell death was suppressed by treatment with 
the caspase-dependent apoptosis inhibitor Ac-DEVD-CHO, but not with 
the necrosis inhibitor IM-54 or the necroptosis inhibitor necrostatin-1, 
indicating apoptotic cell death, as is known for pancreatic β-cell death 
in diabetes [190]. Like H2O2-induced neuronal cell death discussed 
above, H2O2-induced cell death in INS-1 cells was prevented by treat-
ment with TPEN or clioquinol, supporting that alteration in intracellular 
Zn2+ homeostasis is vital for such H2O2-induced cell death [36]. 
Consistently, exposure to H2O2 (200 μM for 2 h) resulted in intracellular 
Zn2+ increase shown using FluoZin-3 staining, which was suppressed by 
treatment with PJ34 or 2-APB. Furthermore, by examining the 
co-localization of FluoZin-3 staining and intracellular organelle-specific 
fluorescent indicators, we showed that labile Zn2+ was mainly present in 
the lysosomes, but not in the ER or mitochondria in INS-1 under control 
conditions and that exposure to H2O2 induced lysosomal Zn2+release, 
which was prevented by treatment with PJ34 or 2-APB [36]. T1D is a 
condition characterised by loss of pancreatic β-cells and to large extent 
can be recapitulated in mice administered with multiple low doses of 
STZ. We showed that mice injected with STZ (40 mg/kg, 6 times daily) 
exhibited extensive loss of pancreatic β-cells, revealed by immuno-
staining of insulin in the pancreas, and hyperglycaemia determined by 
blood glucose levels after overnight fasting. Importantly, these 
STZ-induced detrimental effects on pancreatic β-cells and the 
diabetes-associated phenotype were largely prevented by TRPM2-KO, 
indicating that TRPM2-mediated pancreatic β-cell death is a key 
mechanism in T1D pathogenesis. Consistently, exposure to STZ (2 mM 
for 48 h) led to considerable destruction of pancreatic islets isolated 
from WT mice, which was rescued by TRPM2-KO as well as treatment 
with PJ34 or TPEN [36]. Taken together, these results have led us to 
propose that STZ-induced PARP-dependent TRPM2 channel activation, 
TRPM2-mediated Ca2+ influx and TRPM2-mediated lysosomal Zn2+
release alter intracellular Ca2+ and Zn2+ homeostasis and drive 
apoptotic cell death in pancreatic β-cells and the development of T1D 
(Fig. 6A). 
It is known that accumulation of free fatty acids, a significant risk 
factor in T2D, promotes ROS generation and reduces insulin secretion by 
pancreatic β-cells [191]. A recent study by Li et al. using INS-1832/13 
cells, a subclone of INS-1 cells, has investigated the role of the TRPM2 
channel in pancreatic β-cell death in response to palmitate [121]. 
Exposure to palmitate (500 μM for 12 h) induced apoptotic cell death, 
shown by analysis of annexin V-GFP and PI staining. Like H2O2-induced 
cell death, palmitate-induced cell death was inhibited by treatment with 
PJ34 or TRPM2-siRNA, and also by treatment with TPEN. Consistently, 
extended exposure to palmitate (500 μM for 5 days) resulted in signifi-
cant cell death shown using PI staining in pancreatic islets from WT mice 
but not from TRPM2-KO mice. It was of notice that human pancreatic 
islets, compared to mouse pancreatic islets, were relatively resistant to 
damage by palmitate alone. Nonetheless, extended exposure to palmi-
tate (500 μM) in combination with IL-1β (5 ng/ml) and IFN-γ (5 ng/ml), 
cytokines known to be increased in obesity, for 7 days resulted in sig-
nificant apoptotic cell death determined using TUNEL staining, which 
was reduced by treatment with PJ34, ACA or TRPM2-siRNA [121]. 
These results provide evidence to support a crucial role for the TRPM2 
channel in mediating palmitate-induced alteration in intracellular Zn2+
homeostasis and ensuing apoptotic pancreatic β-cell death, a mechanism 
of potential relevance to T2D pathogenesis. This study went on to 
explore the underlying molecular and signalling mechanism [121]. 
Exposure to palmitate (500 μM for 4 h) led to mitochondrial fragmen-
tation in INS-1832/13 cells that was prevented by treatment with 
apocynin or NOX-2 specific peptide gp91ds-tat and also by treatment 
with NAC, indicating critical engagement of NOX-mediated ROS gen-
eration. Palmitate-induced mitochondrial fragmentation was also 
inhibited by treatment with PJ34 or TRPM2-siRNA. Furthermore, 
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exposure to palmitate (500 μM for 5 days) caused mitochondrial frag-
mentation in pancreatic islets from WT mice, which was not observed in 
pancreatic islets from TRPM2-KO mice [121]. These results support the 
importance of the TRPM2 channel in pancreatic β-cells in coupling 
palmitate-induced NOX-mediated ROS generation and PARP activation 
to mitochondrial dysfunction and apoptotic cell death. As shown for 
H2O2/STZ-induced cell death, alteration in intracellular Zn2+ homeo-
stasis is critical for palmitate-induced TRPM2-mediated mitochondrial 
dysfunction and cell death. Exposure to palmitate (500 μM for 4 h) 
elevated the Zn2+ level in mitochondria that was inhibited by treatment 
with PJ34 or TRPM2-siRNA [121]. Extended exposure to palmitate 
induced mitochondrial membrane permeabilisation showed by the 
diffusion of MitoTracker into the cytoplasm, which was prevented by 
treatment with the Zn2+ chelators TPEN and TPA. Consistently, expo-
sure to palmitate resulted in a reduction of mitochondrial membrane 
potential determined using JC-10 staining, which was also attenuated by 
treatment with PJ34, TRPM2-siRNA or TPEN. These results suggest that 
palmitate-induced PARP-dependent TRPM2 channel activation stimu-
lates mitochondrial Zn2+ accumulation and thereby impairs mitochon-
drial function. Dynamin-related protein 1 (Drp1) is a dynamin-related 
GTPase with a key role in mitochondrial fission [192]. The study, by 
confocal imaging of the subcellular location of GFP-tagged Drp1, 
demonstrated that exposure to palmitate promoted the translocation of 
Drp-1 from the cytoplasm to mitochondria, which was attenuated by 
treatment with PJ34, TRPM2-siRNA or TPEN [121]. Taken together, 
these results show that palmitate induces apoptosis in pancreatic β-cells 
via a molecular and signalling mechanism comprised of NOX activation, 
NOX-mediated ROS generation, activation of PARP and the TRPM2 
channel, TRPM2-mediated lysosomal Zn2+ release, mitochondrial Zn2+
accumulation, mitochondrial fragmentation via Drp1-mediated fission, 
and mitochondrial dysfunction (Fig. 6B). 
7.2. Bile acid-induced pancreatic acinar cell death associated with acute 
biliary pancreatitis 
Acute biliary pancreatitis (ABP) has a multifactorial and complex aeti-
ology [193]. An important factor in ABP pathogenesis is the dysregulation 
of intracellular Ca2+ signalling in pancreatic acinar cells as a result of the 
excessive production of bile acids, and ensuing alteration in intracellular 
Ca2+ homeostasis leads to protease activation, mitochondrial dysfunction 
and ATP depletion that induces necrotic cell death, in addition to mito-
chondrial ROS generation that triggers the apoptotic pathway [194–198]. 
Fanczal et al. have recently examined the role of the TRPM2 channel in 
pancreatic acinar cells, particularly TRPM2-mediated Ca2+ signalling, in 
ABP pathogenesis [46]. Exposure to H2O2 (1 mM) induced intracellular 
Ca2+ increase in pancreatic acinar cells isolated from WT mice that were 
attenuated by removal of extracellular Ca2+, supporting H2O2-induced 
Ca2+ influx. Exposure to 250 μM chenodeoxycholate (CDC), a bile acid, 
induced intracellular Ca2+ increase and also ROS generation in pancreatic 
acinar cells, shown using H2DCFDA (also known as DCFH-DA), a fluores-
cent indicator of cellular ROS. CDC-induced Ca2+ responses were reduced 
in pancreatic acinar cells from TRPM2-KO mice, suggesting that TRPM2 
channel activation is a significant mechanism for bile acid-induced Ca2+
signalling. Exposure to H2O2 (1 mM for 30 min) induced cell death in acinar 
cells isolated from WT mice mainly via necrosis, examined using DNA 
Nuclear Green DCS1 and Apopxin™ Deep Red that stain necrotic and 
apoptotic cells, respectively. Similarly, exposure to CDC (250 μM for 30 
min) also induced necrosis in WT acinar cells. Cell death induced by H2O2 
and CDC was attenuated in acinar cells from TRPM2-KO mice, providing 
strong evidence for TRPM2-mediated H2O2/CDC-induced necrotic cell 
death in pancreatic acinar cells. In addition, short exposure to H2O2 (1 mM) 
or CDC (250 μM) led to a reduction in mitochondrial membrane potential in 
WT acinar cells, measured using tertamethylrhodamine-methyl ester. 
Intriguingly, such an effect on mitochondrial function induced by H2O2, but 
not induced by CDC, was significantly attenuated by TRPM2-KO, indicating 
a TRPM2-independent mechanism for bile acid-induced mitochondrial 
dysfunction. The study further showed that intraductal infusion of mice 
with 4% sodium taurocholate to model necrotising pancreatitis induced 
similar interstitial oedema and leukocyte infiltration in WT and TRPM2-KO 
mice, examined using haematoxylin and eosin (H&E) staining. However, 
the serum amylase activity and the extent of necrosis in the pancreas were 
significantly reduced by TRPM2-KO [46]. Taken together, this study is the 
first to demonstrate an important role for the TRPM2 channel in mediating 
bile acid-induced Ca2+ signalling and necrotic cell death in pancreatic 
acinar cells (Fig. 6C), providing evidence to implicate the TRPM2 channel 
as a previously unrecognised mechanism of ABP pathogenesis. 
Fig. 6. TRPM2-mediated signalling pathways in oxidative stress-induced 
pancreatic cell death associated with diabetes and acute biliary pancre-
atitis. 
(A) STZ-induced cell death in pancreatic β-cells associated with type 1 diabetes. 
Exposure to STZ induces an increase in the ROS level and PARP-dependent 
TRPM2 channel activation, leading to cell death in a signalling pathway 
elucidated mainly based on examining H2O2-induced cell death in INS-1 insu-
lin-secreting cells. Activation of the TRPM2 channel on the cell surface induces 
Ca2+ influx and intracellular Ca2+ increase, and activation of TRPM2 in the 
lysosomes results in lysosomal Zn2+ release. Alterations in intracellular Ca2+
and Zn2+ homeostasis lead to apoptosis. (B) Palmitate-induced cell death in 
pancreatic β-cells associated with type 2 diabetes. Exposure to palmitate trig-
gers activation of NOX for ROS generation. ROS-induced PARP-dependent 
TRPM2 channel activation in the lysosomes results in lysosomal Zn2+ release, 
mitochondrial Zn2+ accumulation, recruitment of Drp1 to mitochondrial and 
Drp1-mediated mitochondrial fission, leading to mitochondrial dysfunction and 
apoptosis. (C) Bile acid-induced cell death in pancreatic acinar cells associated 
with acute biliary pancreatitis. Exposure to CDC induces ROS generation and 
TRPM2 channel activation likely via PARP, leading to intracellular Ca2+ in-
crease and necrotic cell death. Abbreviations: ADPR, ADP-ribose; CDC, cheno-
deoxycholate; Drp1, dynamin-related protein 1; NOX, NADPH oxidase; PARP, 
poly(ADPR) polymerase; ROS, reactive oxygen species; STZ, streptozotocin. 
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8. TRPM2 in kidney cell death associated with acute kidney 
injury and chronic kidney disease 
8.1. Ischemia/reperfusion-induced kidney cell death in acute kidney 
injury 
Ischemic acute kidney injury (AKI) is a frequent complication that is 
caused by acute limitation or deprivation of arterial blood flow to the 
kidneys, particularly by restoration of renal blood supply, and AKI is 
causatively associated with the development of chronic kidney diseases 
(CKD) [199–201]. It has been proposed that excessive production of ROS 
and TNF-α as well as elevation in intracellular Ca2+ concentration in 
kidney cells represent important pathological factors, and that cell 
death, both apoptotic and necrotic, acts as an important cellular 
mechanism in the pathogenesis of AKI. Gao et al. examined the TRPM2 
channel in renal I/R-induced kidney injury [38]. Bilateral kidney 
ischemia followed by reperfusion caused kidney injury in WT mice, 
examined histologically using periodic acid Schiff staining, which was 
attenuated in TRPM2-KO mice. I/R also led to impairment in kidney 
function in WT mice, indicated by increases in the blood levels of urea 
nitrogen and creatinine, which was reduced in TRPM2-KO mice. Such 
kidney damage and loss of function in WT mice were also reduced in 
mice injected with 2-APB prior to ischemia or after reperfusion. A more 
recent study has reported that I/R-induced kidney damage examined 
histologically using H&E staining in WT mice was prevented by treat-
ment with 8-Br-cADPR to antagonise TRPM2 channel activation [112]. 
These studies provide consistent evidence to support an important role 
for the TRPM2 channel in I/R-induced acute kidney injury. In agreement 
with a role for inflammation, I/R resulted in considerable neutrophil 
infiltration into the kidneys of WT mice that was attenuated in 
TRPM2-KO mice. However, selective deletion of TRPM2 expression in 
parenchymal cells, but not in hematopoietic cells protected against 
I/R-induced kidney damage, indicating the TRPM2 channel in kidney 
cells as the major mediator [38]. It is known that I/R causes apoptosis of 
tubular epithelial cells in the kidney [202]. I/R resulted in apoptotic cell 
death examined using TUNEL staining 24 h post-reperfusion and, 
consistently, increases in activation of caspase-3 and caspase-9 and 
cleavage of PARP in kidney cells of WT mice, all of which were reduced 
in TRPM2-KO mice [38]. Conversely, the expression of the 
anti-apoptotic proteins Bcl-2 and Bcl-xL were augmented in the kidney 
of TRPM2-KO mice subjected to I/R. These results support that TRPM2 
channel activation leads to initiation of apoptotic pathways in kidney 
cells. I/R stimulated activation of NOX and increased levels of RAC1, a 
GTPase involved in the activation of NOX, in the kidney cells of WT 
mice, both of which were lessened in TRPM2-KO mice. Furthermore, 
RAC1 was found to interact with the TRPM2 channel, and such 
protein-protein interaction was stimulated by I/R-induced RAC1 acti-
vation, leading to an increase in the cell surface expression of the TRPM2 
channel. Consistently, treatment with the RAC1 inhibitor NSC23766 
before ischemia protected against I/R-induced damage to kidney func-
tion in WT mice. Such treatment also reduced the expression of OS 
biomarkers, NOX activity, PARP cleavage and caspase-3 activation, 
while increasing the level of Bcl-2 in mice subjected to I/R [38]. 
Collectively, these results support an important role for the TRPM2 
channel in coupling OS resulting from I/R-induced NOX-mediated ROS 
generation to activation of apoptotic pathways to drive kidney cell 
death, leading to kidney injury (Fig. 7A). 
8.2. BSA-induced kidney cortical collecting duct cell death associated 
with chronic kidney disease 
Albumin functions as a carrier protein in the blood that transports 
various substances such as fatty acids and hormones around the body 
and is filtered by the glomeruli in the kidneys to be reabsorbed by 
epithelial cells. However, it is known that albumin excreted through 
urine following glomerular injury or tubular damage stimulates ROS 
production and elicits a proinflammatory response in cortical collecting 
duct cells that exacerbates CKD progression [203]. Nazıroğlu et al. have 
recently examined the TRPM2 channel in bovine serum albumin 
(BSA)-induced cellular damage within the kidneys [125]. In the 
mpkCCDc14 murine cortical collecting duct cell line, exposure to BSA 
(25 mg/ml) enhanced the ADPR-induced cationic current that was 
attenuated by treatment with ACA, and also caused an increase in 
intracellular Ca2+ concentration that was reduced by treatment with 
PJ34, DPQ or 2-APB. Prolonged exposure to BSA (25 mg/ml for 24 h) 
induced apoptotic cell death, shown using the APOPercentage apoptosis 
assay, which was reduced by treatment with ACA or the antioxidant 
compound curcumin and, conversely, augmented by treatment with the 
oxidising agent cumene hydroperoxide. Collectively, these results sup-
port that BSA induces apoptotic cell death via PARP-dependent TRPM2 
channel activation. Exposure to BSA (25 mg/ml) stimulated ROS pro-
duction shown using H2DCFDA, and also reduced the ROS-scavenging 
ability of cells indicated by a reduction in the levels of glutathione 
(GSH) peroxidase (GPx) and GSH, both of which were also rescued by 
treatment with curcumin. These results suggest both ROS generation 
and impairment in antioxidant capacity contribute to BSA-induced OS. 
Consistent with BSA-induced apoptotic cell death, exposure to BSA 
caused a reduction in mitochondrial membrane potential determined by 
JC-1 staining and an increase in the activation of caspase-3 and 
caspase-9, both of which were diminished by treatment with ACA or 
curcumin [125]. These results in combination suggest that exposure to 
albuminuria-associated conditions induces OS that in turn activates 
PARP and the TRPM2 channel, and TRPM2-mediated Ca2+ signalling 
Fig. 7. TRPM2-mediated signalling pathways in oxidative stress-induced 
kidney cell death associated with acute kidney injury and chronic kid-
ney disease. 
(A) Ischemia/reperfusion-induced kidney cell death associated with acute 
kidney injury. Exposure to transient ischemia followed by reperfusion increases 
RAC1 activity that stimulates NOX activation and NOX-mediated ROS pro-
duction, activation of PARP and the TRPM2 channel. TRPM2 channel activation 
leads to intracellular Ca2+ increase, downregulation of anti-apoptotic proteins 
(Bcl-2 and Bcl-xL) and activation of caspase-3 and caspase-9 to trigger 
apoptosis. (B) Albumin-induced cell death in cortical collecting duct cells 
related to chronic kidney disease, based on examining BSA-induced cell death 
in mpkCCDc14 murine cortical collecting duct cells. Exposure to BSA increases 
ROS production and reduces antioxidant capacity of the cell by downregulating 
GPx and GSH, increasing intracellular ROS level. PARP-dependent TRPM2 
channel activation results in intracellular Ca2+ increase, contributing to mito-
chondrial dysfunction, activation of caspase-3 and caspase-9 and inducing 
apoptotic cell death. Abbreviations: ADPR, ADP-ribose; BSA, bovine serum al-
bumin; GPx, glutathione peroxidase; GSH, glutathione; I/R, ischemia/reperfu-
sion; NOX, NADPH oxidase; PARP, poly(ADPR) polymerase; ROS, reactive 
oxygen species. 
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initiates mitochondrial dysfunction and apoptotic cell death in kidney 
collecting duct cells (Fig. 7B). These findings provide new insights to 
albuminuria-associated injury to kidneys in the pathogenesis and pro-
gression of CKD. 
9. TRPM2 in hepatocyte death associated with acetaminophen 
overdose-induced liver damage 
Acetaminophen (or paracetamol) is a commonly used analgesic and 
antipyretic drug, though acetaminophen overdose has been well rec-
ognised as a major cause of acute liver damage worldwide by inducing 
hepatocyte death. OS has long been known as a key mediator of 
acetaminophen-induced hepatocyte death and liver damage [204,205]. 
Recent research has drawn attention to the TRPM2 channel for its role in 
acetaminophen-induced hepatocyte death and the underlying signalling 
mechanism [41,206]. Kheradpezhouh et al. showed that exposure to 
acetaminophen (10–15 mM for 1 h) evoked Ca2+ influx to increase 
intracellular Ca2+ concentration and a cationic current in cultured rat 
and mouse hepatocytes [41]. Both acetaminophen-induced Ca2+ influx 
and currents in rat hepatocytes were blocked by treatment with ACA, 
CTZ or TRPM2-siRNA. Acetaminophen-induced Ca2+ influx in rat he-
patocytes was also inhibited by treatment with DPQ. Similarly, 
acetaminophen-induced Ca2+ responses in mouse hepatocytes were 
prevented by treatment with ACA or CTZ, and also by TRPM2-KO [41]. 
Together, these results support that acetaminophen induces Ca2+ sig-
nalling via PARP-dependent TRPM2 channel activation. Prolonged 
exposure to acetaminophen (10 mM for 16 h) led to cell death in rat 
hepatocytes assessed using the trypan blue exclusion method, which was 
inhibited by treatment with ACA [41]. In agreement with 
acetaminophen-induced hepatotoxicity in vitro, liver sections of WT 
mice injected with acetaminophen (500 mg/kg) exhibited extensive 
hepatic necrosis as well as infiltration of lymphocytes and haemorrhage, 
visualised using H&E staining. Furthermore, injection of acetaminophen 
caused liver damage in mice, indicated by an increase in the concen-
tration of the liver enzymes alanine transaminase and aspartate trans-
aminase within the blood determined 24 h following injection. These 
acetaminophen-induced detrimental effects were significantly reduced 
in TRPM2-KO mice. Collectively, this study provides evidence to show 
that TRPM2 channel activation acts as an important mechanism medi-
ating liver damage resulting from acetaminophen overdose (Fig. 8). 
A recent study by Wang et al. has confirmed that exposure to acet-
aminophen (15 mM) reduced the viability of cultured mouse hepato-
cytes, assessed using the MTT assay, which was largely suppressed by 
treatment with CTZ [206]. Intriguingly, it was found that exposure to 
acetaminophen induced cellular ROS generation in mouse hepatocytes 
shown using CM-H2DCFDA, which was also prevented by treatment with 
CTZ. The study also showed that administration of acetaminophen (500 
mg/kg) in mice caused liver cell death shown by H&E staining, and 
damage to liver function indicated by increased serum levels of the liver 
enzymes alanine transaminase and aspartate transaminase. However, 
this study provides evidence to suggest that apoptosis rather than ne-
crosis mediates hepatocyte death resulting from acetaminophen over-
dose. Exposure to acetaminophen (≥15 mM) reduced the level of LC3-II 
in cultured mouse hepatocytes, which was rescued by treatment with 
NAC or CTZ. Detailed examination of the effects of exposure to H2O2 (75 
μM) on autophagy in HeLa cells (without TRPM2 expression) or HeLa 
cells overexpressing recombinant human TRPM2 channel led to identi-
fication of a novel TRPM2-mediated molecular and signalling mecha-
nism for acetaminophen-induced cell death. As illustrated in Fig. 8, 
TRPM2-mediated Ca2+ signalling activates Ca2+/calmodulin-dependent 
kinase II (CaMKII) and CaMKII in turn phosphorylates BECN1 protein, 
which reduces the interaction of BECN1 with PIK3C3 to inhibit auto-
phagy and, at the same time, increase the interaction of BECN1 with 
anti-apoptotic Bcl-2 to induce Bcl-2 dissociation from pro-apoptotic Bax 
protein and promote apoptosis. This finding is consistent with an early 
study showing that OS mediates acetaminophen-induced hepatocyte 
death by inhibiting autophagy [207]. Wang et al. have further shown 
that acetaminophen-induced decrease in the level of LC3-II in mouse 
hepatocytes was prevented by treatment with the calmodulin inhibitor 
W-13 or the CaMKII inhibitor KN-93 [206]. Similarly, 
acetaminophen-induced liver injury in WT mice, revealed by H&E 
staining of liver sections and by measuring serum liver enzymes, was 
mitigated by treatment with KN-93 [208]. These results support CaMKII 
as a key signalling molecule in the above-described TRPM2-mediated 
molecular and signalling mechanism that mediates 
acetaminophen-induced apoptotic cell death in hepatocytes and liver 
damage (Fig. 8). 
10. Concluding remarks and perspectives 
OS has been well recognised as a salient and common feature in, and 
more importantly a significant pathological factor for, various diseases 
and conditions. It is evident from the above discussion that the TRPM2 
channel, expressed in a variety of cells and tissues, plays an important 
role in mediating OS-induced cell death and damage to the physiological 
functions of diverse cells and tissues via alteration of intracellular ion 
homeostasis, particularly Ca2+ and Zn2+, and disruption of diverse 
molecular and signalling mechanisms. As summarised in Table 1, 
increasing evidence supports such TRPM2-mediated cell death as an 
important cellular mechanism coupling OS induced by a diverse range of 
pathological factors to associated pathological conditions. It is known 
that distinct mechanisms direct cell death such as apoptosis, necrosis, 
necroptosis and autophagy [208]. Considerable progress has been made 
in developing a mechanistic understanding of how OS-induced TRPM2 
channel activation triggers cell death via apoptosis, necrosis or auto-
phagy, and nevertheless the cell death pathways are still not clearly 
defined in many cases. In addition, it remains less clear why TRPM2 
channel activation in different cell types by pathology-specific factors 
initiates distinct signalling mechanisms and death pathways. Further 
efforts are required to understand whether such TRPM2-mediated cell 
death mechanisms are intrinsic to specific cell types, depend on the 
nature of OS-inducing pathological factors, or both. For example, 
ZnO-NPs-induced TRPM2 channel activation stimulates autophagy to 
induce apoptotic cell death in pericytes and, by contrast, acetaminophen 
overdose-induced TRPM2 channel activation subverts autophagy in 
order to enhance apoptotic cell death in hepatocytes. It is also noted that 
a number of studies show that the TRPM2 channel, besides acting as a 
sensor or mediator for OS, also participates in the induction of OS in 
diverse cell types upon exposure to various pathological factors. Our 
studies in hippocampal neurons and also in SH-SY5Y cells have led us to 
propose that TRPM2 channel activation is central to a vicious positive 
Fig. 8. TRPM2-mediated signalling pathways in oxidative stress-induced 
hepatocyte death associated with acetaminophen overdose-induced 
liver damage. 
Exposure to high concentrations of acetaminophen leads to OS by increasing 
ROS production in hepatocytes, and subsequent PARP-dependent TRPM2 
channel activation and intracellular Ca2+ increase. Ca2+ activates CaMKII that 
in turn phosphorylates BECN1 protein, thereby reducing autophagy and stim-
ulating apoptosis. Abbreviations: ADPR, ADP-ribose; BECN1, Beclin-1; CaMKII, 
Ca2+/calmodulin-dependent protein kinase II; PARP, poly(ADPR) polymerase; 
ROS, reactive oxygen species. 
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feedback mechanism driving ROS/Aβ-induced neuronal cell death [82, 
124]. Such a mechanism offers an appealing explanation to the 
intriguing observation that acetaminophen-induced ROS generation in 
mouse hepatocytes was prevented by inhibition of the TRPM2 channel 
with CTZ [206]. It is likely that a similar positive feedback mechanism is 
engaged in TRPM2-mediated cell death in other cell types discussed 
above. It is worthwhile to mention that activation of the TRPM2 channel 
in phagocytes can induce membrane depolarisation that suppresses the 
activity of membrane potential-sensitive NOX and thereby reduces 
NOX-mediated ROS generation, a negative feedback mechanism that is 
important for the role of the TRPM2 channel in protecting against 
LPS-induced lung inflammation [209]. Therefore, a better understand-
ing of the role of the TRPM2 channel in the pathogenesis of 
OS-associated diseases is crucial for rationalising the strategies of 
developing therapeutics. Taking AD as an example, in addition to the 
positive feedback mechanism we have proposed for TRPM2-mediated 
neuronal cell death, numerous other feedback loops among the key 
events in the amyloid cascade hypothesis of AD have been identified to 
occur both at the level of generation and aggregation of Aβ peptides 
[210] and also at the level of interactions among different cell types in 
the brain [211]. These findings and new insights lead to the interesting 
proposal of the feedback hypothesis instead of the prevailing amyloid 
cascade hypothesis of AD. There is increasing evidence to suggest that 
breaking such positive feedback loops is a promising approach to 
intervene in the pathogenesis and progression of AD [212]. Currently, 
there are no effective treatments, or a substantial unmet clinical need, 
for many debilitating diseases or conditions of which the TRPM2 
channel plays an important part in the pathogenesis and progression. 
The findings discussed above have raised an interesting and exciting 
perspective of the TRPM2 channel as a new target. Development of 
TRPM2-specific and metabolically stable ligands, including agonists, 
antagonists and modulators, is the prerequisite for testing the concept of 
targeting the TRPM2 channel as a novel avenue of developing treat-
ments for OS-associated diseases and conditions. 
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